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ABSTRACT 
 
 The mammalian ovary is comprised of follicles at various stages of growth and is 
responsible for gamete and steroid hormone production. Conservation of ovarian function 
is vital for female reproductive and general health, and disruption can lead to infertility 
and/or ovarian senescence.  Stressors affect the ovary by inflicting damage to the 
primordial oocyte and/or inducing follicular activation thereby depleting the follicular 
reserve and disrupting biological pathways or defense mechanisms necessary for 
maintaining proper ovarian function.    Cyclophosphamide (CPA) is a chemotherapy drug 
that biotransforms into an ovotoxic metabolite phosphoramide mustard (PM) via hepatic 
biotransformation. Our previous findings demonstrated that PM (60 µM) exposure 
depleted primordial follicles as well as all follicle types in cultured postnatal day (PND) 4 
rat ovaries. With the advancement of science and medicine, there has been a decline in 
mortality rates of females who receive chemotherapy.  The viability and health of the ovary 
post-chemotherapy treatment is of major concern for female cancer survivors due to the 
harsh effects of anti-neoplastic agents. An ovarian defensive mechanism would challenge 
the adverse effects of PM-induced ovotoxicity.  We hypothesized that the ovarian defense 
response to PM-induced damage involves both the ABCB1 and ABCC1 proteins to excrete 
PM from the ovary and that their regulation involved the PI3K pathway. ABCB1 and 
ABCC1 are involved phase III chemical biotransformation, having enzymatic activity that 
requires ATP derived energy for the transportation of endogenous and exogenous 
compounds.  Briefly, PND4 rat ovaries were cultured in PM (60 µM), LY294002 (20 µM), 
or vehicle control (1% DMSO) followed by protein isolation and western blotting.  Adult 
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female mice (15 wks) were intraperitoneally (i.p) dosed once with sesame oil (SO) or PM 
(95%; 25 mg/kg), euthanized 3 days post dosing followed by removal of ovaries and 
fixation in paraformaldehyde (4%).  Ovaries were sectioned and mounted on slides 
followed by immunohistochemistry (IHC) performance to localize ABCC1 and ABCB1 
proteins.  PM exposure decreased ABCB1 protein abundance in PND4 cultured rat ovaries, 
however, no impact was observed in ABCC1 in either PND4 or cultured ovarian rat 
granulosa cell models.  Localization of ABCB1 and ABCC1 in PND4 ovaries was observed 
in the oocyte cytoplasm post PM exposure.  ABCB1 was localized in granulosa cells, 
interstitial tissue, and the oocyte of adult mice ovaries, and there was striking ABCB1 
oocyte peri-cytoplasmic and peri-nuclear immunofluorescence staining.  ABCC1 was 
localized in the nucleus of oocyte in PND4 ovaries, but confined to theca cells, oocyte 
cytoplasm, and interstitial tissue of adult mouse ovaries.  Additionally, pre-ovulatory 
follicles expressed ABCC1 in the oocyte peri-cytoplasmic membrane in control animals, 
but this staining pattern was absent in PM-exposed mice.  In regards to PI3K, inhibition 
resulted in down regulation of both ABCB1 and ABCC1, however, PI3K activation via kit 
ligand treatment had no effect on ABCB1 or ABCC1.   
 Heat stress has a negative impact on agriculture livestock production. Our previous 
studies suggested that HS alters ovarian steroidogenic signaling impacting the productivity 
of reproduction in swine (Nteeba et al., 2015).  This thesis investigated whether SULT1E1 
and ABCC1 were involved in metabolism and excretion of 17β-estradiol synthesis during 
HS.  It was hypothesized that HS alters SULT1E1 and ABCC1 impacting 17β-estradiol. 
Briefly, pre-pubertal gilts were exposed to thermoneutral (TN; 20°C) or heat stress (HS; 
35°C) conditions for 5, 7, or 35 d with an additional group of thermoneutral pair-fed 
xii 
 
 
(PFTN) gilts included to eliminate bias of feed intake followed by protein isolation, RNA 
isolation, western blotting, and qRT-PCR. Additionally, post-pubertal gilts were 
synchronized in their follicular phase with Matrix feeding and exposed to TN (20.3°C) or 
HS (26-32°C) conditions for 5 d followed by protein isolation, RNA isolation, western 
blotting, and qRT-PCR. We found that chronic HS (35 d) of pre-pubertal gilts increased 
both ABCC1 and SULT1E1 protein abundance without having an effect at the 
transcriptional level.  HS during the follicular phase in post-pubertal estrous synchronized 
gilts resulted in reduction of ABCC1 mRNA levels and increased levels of SULT1E1 
protein, but no impact on ABCC1 protein was observed.  The data generated from these 
studies suggest that PI3K plays a critical role in ovarian phase III biotransformation 
enzymes providing evidence that the ovary has the ability to conduct phase III drug 
metabolism and that SULT1E1 and ABCC1 are active in the ovary and may alter 17β-
estradiol metabolism during HS.   
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ORGANIZATION OF THE THESIS 
 
 The main focus of this thesis regards PM-induced ovotoxicity and HS-induced 
steroidogenic disruption impacting ovarian function followed by defense mechanisms 
along with identification of ovarian proteins affected.  It is organized in four separate 
chapters including a table of contents section.  Chapter 1 details general background 
information on ovarian physiology, folliculogenesis, steroidogenesis, hypothalamic-
pituitary-gonadal axis, ovotoxicity, heat stress, biotransformation enzymatic activity, and 
role of PI3K pathway.  Chapter 2 consists of specific information on the project in regards 
to PM toxicity of the ovary and phase III biotransformation defensive mechanisms that are 
regulated by PI3K pathway signaling in ovarian rat models.  Chapter 3 investigates the 
effects of heat stress on ovarian SULT1E1 and ABCC1 in pre-pubertal and cyclic gilt 
ovaries.  Chapter 4 is a discussion of the literature review, data, and future research ideas 
from the author’s perspective. 
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CHAPTER 1  
GENERAL INTRODUCTION 
Ovarian Physiology 
The female reproductive system, is comprised of the ovaries, uterus, fallopian tubes, 
vagina, vulva, and mammary gland, which are collectively vital for the facilitation of 
gamete development, fertilization, pregnancy maintenance and nourishment of the 
offspring.   The ovary is the major female gonad and has two main functions: to produce 
1) the female sex steroid hormones (17β-estradiol (E2) and progesterone (P4)) and 2) the 
female gamete, the oocyte.  The ovaries are located on the right and left side of the pelvic 
body cavity and contain follicles that consist of the oocyte, granulosa and theca cells, 
dependent on the stage of follicular maturation (Figure 1.1) [1]. 
 
In humans, oogenesis is a process for the production of oocytes that occurs in the fetal 
developmental stage prior to birth where the female will produce all the oocytes that will 
be used during the entire lifespan, comprising the ovarian reserve [2].  This process 
involves both mitosis and meiosis, where initially oogonia produce oocytes through mitosis 
[3-7].  Briefly, the oocyte undergoes meiosis but it is arrested during prophase I of the 
diplotene stage until menarche [3, 8, 9].  The female follicular pool consists of a finite 
population:  the gestational population of oocytes ranges around 14 million and decreases 
drastically at birth with an estimation of 1.5 million.  At puberty onset the number of 
oocytes further declines to approximately 300,000.  Considering that women ovulate only 
400-500 oocytes during a lifetime, a fraction of oocytes mature to ovulation.  The majority 
of oocytes die by a process known as atresia.  By the time a woman enters menopause there 
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remain approximately 100 oocytes in the follicular pool [2, 3].  Follicular depletion is 
irreversible, thus, reproductive senescence ensues, known as menopause in humans [10].   
 
Folliculogenesis  
The ovary is a compartmentalized structure that contains follicles at different maturation 
stages (Figure 1.1).  These classification of follicles include primordial, primary, 
secondary, and antral follicle stages.  Folliculogenesis is the process where primordial 
follicles mature to pre-ovulatory follicles via regulation by both paracrine and endocrine 
factors [11].  Follicles are produced from primordial germ cells (PGCs) that migrate to the 
genital ridge and settle in the mass of mesoderm on dorsal body wall (indifferent gonad) 
[12-14].  The somatic cells (granulosa, theca, endothelial, interstitial tissue) of the follicle 
are descended from the embryonic indifferent gonad, which consists of mesenchyme from 
the genital ridge [3, 15]. Following invasion of the indifferent gonad, PGCs lose their 
motile function and undergo rapid proliferation [13, 14, 16].  The PGCs undergo mitosis 
while the somatic cells also continue to rapidly divide [13].  The PGCs become clustered 
together and the somatic cells enclose the PGCs by development of histologically distinct 
cord structures.  In the rat and mouse model, ovarian cords are not sharply defined but they 
are very distinctive in the pig [3].   The ovarian cords are responsible for separating the 
embryonic ovary into two compartments that are divided by a basement membrane.  The 
embryonic ovary contains an epithelioid compartment containing PGCs and an interstitial 
compartment without PGCs [17, 18].  Completion of PGC mitotic division results in their 
transformation to begin prophase of meiosis, however, the oocyte is arrested at the 
diplotene stage [6].  In humans, oocytes enter meiosis by 2 months post-coitum [19], at day 
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17.5 post fertilization (pf) in the rat [20], and day 14 pf in the mouse [21].  The somatic 
cells within the ovarian cords continue to proliferate throughout the embryonic phase and 
they enclose oocytes into germ cell nests, precursors of primordial follicles.   
 
Primordial follicles consist of an oocyte surrounded by a single layer of flattened granulosa 
cells and the basal lamina [7] (Figure 1.2).  Primordial follicles can remain dormant for 
months or years.  The fate of primordial follicles rely on a process known as initial 
recruitment where intraovarian factors stimulate activation of primordial follicles into the 
growing follicular pool [11].  This process occurs after primordial follicle formation even 
prior to pubertal onset [11].  As growth occurs, the flattened granulosa cells resume 
proliferation and assume a cuboidal morphology, the size of the oocyte increases, and 
formation of a non-cellular layer between the oocyte and granulosa cells known as the zona 
pellucida (ZP) occurs [22-24], forming a primary follicle (Figure 1.2).  In primary follicles, 
the granulosa cells and oocyte makes contact by transmission of microvilli through the ZP 
forming gap junctions with the oocyte [3].   
 
Further follicle development results in the formation of the secondary follicle stage where 
2-3 layers of granulosa cells are present.  Secondary follicles are also referred as pre-antral 
since they lack an antrum.  At this stage, recruitment of an additional theca cell layer occurs 
[25].   Arterioles attach to the theca cell layer in order to facilitate a self-regulating blood 
supply [26].  The thecal layer consists of an outer layer, the theca externa, and an inner 
layer, the theca interna.  The theca externa mainly contains nerves, blood vessels, and 
connective tissue while the theca interna layer is entailed of steroid-producing cells.  Theca 
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cells are thought to be recruited from ovarian stroma by factors that are released from 
activated follicles [2, 3].   
 
The antral, or Graafian follicle, is the largest follicle that is both LH- and FSH-dependent.  
It is also a major site for protein and steroid synthesis.  At this point, the granulosa cells 
further proliferate into the corona radiata and cumulus oophorus.  The corona radiata is a 
single layer of granulosa cells adjacent to the ZP that sustain gap junction for intercellular 
transport of metabolites and nutrients to the oocyte [27].  The multilayer granulosa cells 
that surround the corona radiata are the cumulus oophorus that are attached to the corona 
radiata during ovulation and detach into the oviduct afterwards.  Mural granulosa cells, 
which are granulosa cells located next to the basal lamina, contain the most LH receptors 
in mature follicles.  Once the connections with the granulosa cells forming the corona 
radiata and mural cells are disrupted, it causes a secretion of fluid that forms a cavity known 
as the antrum.  The follicular fluid inside the antrum is a very rich steroid environment and 
contains thecal blood constituents [28].  Fully mature follicles also house insulin-like 
growth factor (IGF-1) receptors, gonadotropin-releasing hormone (GnRH) binding sites, 
and steroidogenic enzymes, which are discussed in a later section [29-35].   
 
Towards the end of the follicular phase, an LH surge causes the pre-ovulatory follicle’s 
cumulus oophorus layer to develop an opening, expelling the oocyte from the follicle in a 
process known as ovulation [36].  By this point, meiosis I resumes and the first polar body 
is formed resulting in a haploid oocyte.  The primary oocyte is now considered a secondary 
oocyte and meiosis II is initiated [5-7, 13, 21, 37].  
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The corpus luteum (CL) is a temporary endocrine structure that is morphologically and 
biochemically generated from transformed theca and granulosa cells.  It synthesizes the 
production of progesterone (P4) that is necessary for the maintenance of pregnancy.  The 
CL is developed during the luteal phase of the estrous or menstrual cycle and converts to a 
blood filled follicular structure, called the corpus hermorrhagicum, immediately following 
ovulation.  In humans and animals with long estrous cycles, such as the pig, the CL forms 
right after ovulation during the luteal phase of the cycle.  Eventually, if fertilization does 
not occur, the CL undergo luteolysis forming a corpus albicans.  In humans, this process is 
not well investigated, but is hypothesized to be caused by prostaglandin F2alpha (PgF2α) 
[2].   
 
In contrast to initial recruitment, cyclical follicle recruitment after pubertal onset is initiated 
by an FSH spike that rescues a cohort of antral follicles for ovulation and potential 
fertilization during each reproductive cycle [11].  Follicle recruitment is associated with 
slight increase in circulating FSH.  For example, rats exhibit a secondary spike of FSH on 
the day of estrus before the following cohort of ovulatory follicles are recruited [38].  Basal 
FSH is slightly elevated at the beginning of the follicular phase compared to the later or 
luteal phases in primates [39, 40].  Early antral follicle size in rats that are considered as 
recruitable range between 0.2-0.4 mm in diameter, whereas human follicles are larger, 
being 2-5 mm in diameter [11].  Follicles that are not recruited undergo atresia via a default 
pathway [11].  It is still unclear to why out of a cohort of 10 dominant follicles in young 
women only one develops faster than the rest and produces high levels of inhibin and 
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estrogens.  It is suggested that the dominant ovulatory follicle may be more sensitive to 
FSH due to the higher expression of FSH/LH receptors [41-43].   It is also suggested that 
E2 and inhibin secretion from the largest follicle can suppress pituitary FSH release during 
the mid-follicular phase which is needed for survival in the other growing follicles [44].  
Administration of exogenous E2 in women suppresses follicle development while 
exogenous administration of gonadotropins increased the growth rate of multiple pre-
ovulatory follicles [45-47].  This demonstrates the negative selection of subsidiary follicles 
as a result of the negative feedback by the dominant follicle through inhibin and E2 
production [11].    
 
The human menstrual cycle is quite variable ranging from 23-35 days with 14 days therein 
comprising the luteal phase, which is the time between ovulation and menstruation [2].  
Unlike humans, in domestic animals including pigs, the first day of the estrous cycle is 
dictated by the female being in behavioral heat and receptive to the male.  In pigs, the 
estrous cycle is approximately 21 days in length and consists of the follicular phase (pro-
estrus and estrus) and the luteal phase (metestrus and diestrus).  Pigs are a polytocous 
species ovulating 15-30 oocytes per cycle [48].  The rodent estrous cycle is 4-6 days and 
also consists of estrus, proestrus, diestrus, and metestrus stages.  Interestingly, primordial 
follicle formation via germ cell nest breakdown occurs during the fetal life of humans, 
primates and domestic animals, whereas in rodents it occurs post-parturition [8].   
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Steroidogenesis  
A second major function of the ovary is the synthesis of sex hormones through 
steroidogenesis.  The major products of steroidogenesis are estrogens (E2 and estrone-3 
sulfate) and P4 [49].  The process is initiated when the ovary obtains cholesterol as either 
the dietary form of cholesterol bound to low density lipoproteins (LDL) or via de novo 
synthesis from acetyl-CoA as a precursor [50].  Cytochrome P450 (CYP) enzymes mediate 
each stage of ovarian hormone synthesis where steroidogenic acute regulatory protein 
(StAR) enables cholesterol transportation from the outer into the inner mitochondrial 
membrane where it is then converted to pregnenolone via CYP11A1 and P450-side chain 
cleavage (CYP450scc) enzymes.  Pregnenolone is exported to the cytoplasm and 
undergoes conversion to P4 by 3β-hydroxysteroid dehydrogenase (3βHSD).  Pregnenolone 
can also be converted to 17α-OH-pregnenolone via CYP17 which is further processed into 
dehydroepiandrosterone (DHEA), a weak androgen.  DHEA is converted into 
androstenedione by 3βHSD and then P4 is converted to androstenedione by CYP17.  
Androstenedione induces the formation of testosterone by 17β-hydroxysteroid 
dehydrogenase (17βHSD).  Both testosterone and androstenedione can be metabolized to 
E2 and estrone via aromatase, CYP19a [2, 49, 50].   
 
The steroidogenic process is mediated by granulosa cells (GC) and theca cells (TC) within 
the ovary through stimulation by FSH and LH.  Both GC and TC express CYP11A1 and 
StAR [51], however, GC do not express CYP17A [52] therefore synthesis of pregnenolone 
from cholesterol occurs along with subsequent conversion to P4 in the CL.  In the late 
follicular phase, the preovulatory follicle primarily produces E2 [49].  The follicle is 
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dependent on the interaction between the GC and TC and therefore, production of 17β-
estradiol is referred to as the two-cell-two gonadotropin theory [34, 53-59].  As the follicle 
approaches ovulation, the GC increase the synthesis of P4, is required for luteinization 
initiation [2, 49]. 
 
The hypothalamic-pituitary-gonadal (HPG) axis 
The hypothalamic-pituitary-gonadal (HPG) axis is a system that consists of a hormonal 
interaction between the hypothalamus, anterior pituitary gland, and the female gonads and 
is regulated by both negative and positive feedback mechanisms [60] (Figure 1.4).  The 
hypothalamus is located beneath the thalamus and forms a lateral wall and floor of the third 
ventricle. It encompasses neurosecretory tissue and extends to the anterior pituitary gland 
where it influences hormone production [61].  It contains three different zones 
(periventricular, lateral, and medial) and the arcuate nucleus that is important for 
gonadotropin releasing hormone (GnRH).   The secretion of GnRH is vital for stimulation 
of gonadotrophs in the anterior pituitary [61] that produce the gonadotrophins; FSH and 
LH.  The pituitary gland functions as the master endocrine gland and contains two major 
components: the anterior and posterior lobes, with the anterior lobe being particularly 
pertinent to control of the mammalian reproductive cycle [61].   
 
The HPG axis regulates the proliferative (follicular) phase, ovulation, and the secretory 
(luteal) phase, of the estrous/menstrual cycle.  The initiation of the HPG process begins 
with the onset of menses, the mechanisms of which remain to be fully elucidated.   The 
hypothalamus releases GnRH into the anterior pituitary where it stimulates FSH and LH 
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production and release.  FSH promotes follicular development leading to the production of 
E2 from multiple layers of GC.  LH signals the TC for the production of androgens where 
they are transported to the GC to be transformed into E2 [49].  Elevated E2 from the 
dominant follicle(s), positively feedback onto the hypothalamus and pituitary, thereby 
causing the LH surge that is critical for ovulation [61].   
 
Activin produced by GC amplifies FSH secretion by boosting formation of GnRH 
receptors [62, 63]. However, activin is inhibited by inhibin and follistatin.  Inhibin is a 
polypeptide that is also secreted from the GC in response to FSH [64] and has the ability 
to inhibit FSH secretion from the anterior pituitary via negative-feedback regulation [65].  
Follistatin is also a peptide that can inhibit FSH secretion and synthesis by requisition of 
activin [66, 67].  Inhibition of follistatin is promoted by inhibin while activin stimulates 
follistatin production [66, 67].     
 
The residual GC content that are left behind after ovulation form the P4-producing CL.  P4 
converts the endometrial lining of uterus to the secretory phase for embryo implantation 
[61].  If a pregnancy occurs, the maternal recognition of pregnancy signal maintains the 
CL for production of P4 suppressing the release of GnRH through negative feedback on the 
hypothalamus  [61]. However, if fertilization does not occur, the CL undergoes a luteolysis 
process forming the corpus albicans which encourages the P4 decline resulting in 
endometrium instability signaling a new menstrual cycle [61].   
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The HPG axis therefore regulates promotion of follicle maturation and ovulation [68] as 
well as sex steroid hormone (E2 and P4) production.  E2 is important for female secondary 
sex characteristic at puberty and development of mammary glands for lactation while P4 is 
critical for implantation of the blastocyst and maintenance of pregnancy. 
 
Ovarian senescence 
Approximately 11 percent of women are infertile [69]  for which the etiology is unknown 
but may involve environmental exposures or genetic causes [70].  As mentioned 
previously, viability and maintenance of the primordial follicular pool is important because 
once depleted they cannot be replaced [71, 72].  Women typically experience the onset of 
menopause on average by 52 years of age [10, 73, 74].  Premature ovarian failure (POF) is 
defined as menopause onset prior to 40 years of age. POF can be induced due to 
hypoestrogenism and/or elevated abundance of gonadotropins that can lead to exhaustion 
of the ovarian follicular pool [75]. It is also induced by altered HPG axis function which 
disrupts the proper synthesis of the sex steroid hormones [76].   
 
Xenobiotic-induced infertility 
Ovotoxicants are chemicals which detrimentally affect ovarian function (Table 1.1).  They 
can affect primordial or growing follicle viability, folliculogenesis or steroidogenesis [70] 
and can lead to infertility or POF [73, 77].  The stage of follicle development targeted by 
an ovotoxicant determines the impact on reproduction.  Disruption to antral follicle 
viability results in short-term deficiency due to the ability for replacement of follicles via 
recruitment from the finite primordial pool, thus once the exposure is removed, fecundity 
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is restored [77].  Destruction of primordial follicles represents a more insidious exposure 
since permanent infertility and POF can be induced which may not be recognized for 
months or years and for which there is no replacement [70].  Additionally, the life stage of 
exposure can impact the reproductive outcome: prenatal exposures could affect the PGC 
population; neonatal exposure could affect puberty onset; reproductive life span exposures 
can impact fertility, pregnancy maintenance or lactation and post-menopause exposures 
can increased neoplasm development in reproductive tissues [71] (Figure 1.3).    
 
Cyclophosphamide (CPA) is an alkylating agent used to treat a wide range of cancers and 
autoimmune diseases [78, 79].  CPA can either be administered alone or given in a cocktail 
formula with other drugs [78].  CPA is a pro-drug that requires hepatic biotransformation 
by cytochrome P450 (CYP) enzymatic activity for transformation into its anti-neoplastic 
metabolite, phosphoramide mustard (PM) [80, 81].  Bioactivation of CPA to PM is initiated 
by CYP isoforms 3A and 2B [82].  As a detrimental side effect of CPA/PM treatments in 
females, PM induces primordial, small primary, and growing follicle loss [79, 83].  PM 
can further spontaneously transform into a volatile, cytotoxic compound, 
chloroethylaziridine (CEZ) [84], which negatively affects ovarian function [79].  Previous 
research from our group demonstrated that depleted primordial and growing follicles [79].   
Exposure to an ovotoxicant that targets and destroys both pre-antral and growing follicles 
can accelerate ovarian senescence introducing a risk to general female health. 
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Xenobiotic biotransformation  
Xenobiotic biotransformation enzymes (XBE) are involved in bioactivation, detoxification 
and/or excretion of xenobiotics [85].  Phase I chemical metabolism involves hydrolysis, 
reduction, and oxidation.  Phase I XBE consist primarily of the cytochrome P450 (CYP) 
enzymatic family [86].  These enzymes are abundant in all tissues and participate in 
activation or detoxification of chemicals [86].  Epoxide hydrolases (EH) are also phase I 
biotransformation enzymes and consist of 5 different forms, microsomal EH being an 
example [86], which catalyzes water addition to arene oxides and alkene epoxides [86, 87]. 
 
Phase II XBE action generally enhances excretion in bile and urine by increasing 
hydrophilicity of the chemical [87].  There are a number of phase II biotransformation 
processes including sulfonation, glucuronidation, glutathionylation, acetylation, 
methylation [86].  Glutathione S-transferase (GST) isoforms alpha, pi, mu, omega, and 
theta catalyze glutathione (GSH) xenobiotic conjugation [86, 88].  Gonadotropins regulate 
GSH synthesis [89] and mice undergoing ovarian senescence had decreased concentrations 
of GSH [90, 91].  GSH is plentiful in all cells, as an antioxidant composed of glutamic acid, 
cysteine, and glycine [86].  The ovary has excessive amounts of GSH [92, 93] and ovulated 
oocytes contain the highest concentration of GSH compared to any cell type [94].    
 
Phase III XBE’s generally comprise drug transporters that excrete and transport foreign 
and endogenous compounds from the cell [87, 95-98]. The ATP-binding cassette (ABC) 
proteins are a large phase III XBE protein family [87, 97, 99, 100].  ABC proteins have the 
ability to derive energy from ATP hydrolysis to: 1) drive transmembrane movement of 
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specific substrates, 2) regulate penetrability of multi-channel complexes, and 3) open or 
close certain membrane channels [101].   The most studied ABC transporters are the multi-
drug resistance protein (ABCB1), also known as p-glycoprotein, and the multi-drug 
resistance associated protein (ABCC1) [101].  ABCB1 confers multidrug resistance to 
cancer cells thereby enabling their evasion of anti-neoplastic chemotherapy treatments 
[102-105].  ABCB1 is approximately 170 kDa in size  (Higgins, 1992; Croop, 1993; 
Gottesman, 2002) and transports positively charged or uncharged hydrophobic compounds 
that have been made water soluble by phase I and/or II biotransformation [106].  ABCC1 
also causes multidrug resistance phenotype in cancer cells [107-113].  ABCC1 is 
approximately 190 kDa in size and transports organic anions, hydrophobic compounds, 
sulfates, glucuronates, 17β-glucuronosyl estradiol, bisglucuronosyl bilirubin, and 
conjugated GSH substrates [101].   
 
Regulation of phase I, II, and III XBE’s involve signaling regulated by the arylhydrocarbon 
receptor (AHR) [114, 115] and nuclear factor erythroid related factor 2 (NRF2) [116].  
AHR, a member of the basic helix loop-helix (bHLH) DNA binding proteins [117],  is 
located in the cytoplasm within a complex of heat shock protein (HSP) 90 during 
homeostatic conditions [118]. However, after activation AHR translocates to the nucleus, 
where it dimerizes and binds to xenobiotic response element (XRE) of target gene 
promoters [118].  NRF2 is a member of the “cap ‘n’ collar basic leucine zipper” (CNC-
bZip) proteins where it is to bound to kelch-like ECH-associated protein (KEAP1), a 
repressor protein, in the cytoplasm until cells are exposed to stressful conditions requiring 
action [119, 120].  
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The phosphatidylinositol-3 kinase pathway  
Phosphatidylinositol-3 kinase signaling pathway (PI3K) is imperative for viability of 
primordial follicles [121] as well as their activation into the growing follicle pool [122-
126].  In primordial and small primary follicles, PI3K is regulated by  kit ligand (KITLG), 
which is synthesized in the GC [127] and which binds to the oocyte c-kit receptor [128-
131] initiating c-kit auto-phosphorylation which in turn activates PI3K [132].  KITLG-
cKIT interaction is involved in initiation of oocyte growth during primordial follicle 
growth activation [133, 134].  PI3K signaling is negatively impacted by exposure to the 
ovotoxicant 4-vinylcyclohexene diepoxide (VCD) [135, 136] and inhibition of the pathway 
protected primordial follicles from VCD-induced follicle loss [137].  Exposure to VCD 
reduced PI3K signaling in primordial and small primary oocytes [135, 136] by decreasing 
phosphorylation of c-Kit [138] and over expressing pAKT [136] in PND4 cultured rat 
ovaries.  The pathway is also involved in regulation of ovarian XBE’s [139, 140].  Both 
mRNA and protein abundance of the XBE genes, meh, Ahr, Nrf2, Gstp, and Gstm were 
increased when PI3K inhibition was induced in cultured rat ovaries [139, 140].  Thus, 
ovarian PI3K regulates not only primordial follicle activation and growth, but also 
contributes to phase I, phase II, and phase III xenobiotic biotransformation.   
 
Heat stress and reproduction  
Heat stress (HS) is a thermal imbalance between the net amount of energy flowing from an 
animal to its surrounding environment which can induce several physiological issues [141].  
The United States livestock industry endures economic losses due to HS, and seasonal 
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infertility induced by HS is estimated by our group to exceed $420 million annually 
(Pollman, Ross, Baumgard, Keating, unpublished data).  HS negatively affects female 
reproduction and is phenotypically observed in swine and other species as irregular estrous 
cyclicity [142-144], reduced conception rate [145, 146], reduced embryonic survival [147], 
and higher frequency of stillbirths [146, 147].  The etiologies behind compromised 
reproductive efficiency due to HS are unknown, and hyperinsulinemia observed during HS 
[148, 149] could be one causative factor since insulin can activate PI3K signaling.  HS has 
the potential to alter PI3K signaling which is involved in regulation of ovarian 
steroidogenesis [150], activation of primordial follicles [122-125, 151-153], maturation 
and viability of the oocyte [121].  A study investigated impacts of HS on ovarian signaling 
pathways critical for ovarian function in pre-pubertal gilts and demonstrated increased 
ovarian insulin signaling, PI3K signaling as well as altered mRNA abundance of genes 
involved in these processes [154].  HS also affected ovarian steroidogenesis and mRNA 
and protein abundance of CYP19a1 and STAR were observed to be increased [154].  
Altered steroid hormone production within the ovary, either by the dominant follicle or CL 
could lead to a reduction in fertility and impair embryonic viability [154].   
 
Summary  
This literature review details basic components of the female reproductive system and 
illustrates the susceptibility of the ovarian follicular pool that could contribute to infertility 
and/or POF.  The complexity of the ovary demonstrates that there are many processes that 
contribute to proper ovarian function and efficient reproduction in the female.  
Folliculogenesis regulates proper maturation of the oocyte and surrounding follicular 
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structure, and culminates in production of E2 synthesis which regulates secondary sex 
characteristics in conjunction with the hypothalamic pituitary gonadal axis.  The 
homeostasis of the ovary can be interrupted by environmental endocrine disrupting 
chemicals, commonly used anti-neoplastic agents (CPA/PM), and environmentally natural 
occurrences such as heat stress; all of which can lead to infertility and/or reduced fecundity.  
Chemical biotransformation enzymatic activities are biological defense methods.  The 
phase III biotransformation enzymes, ABCB1 and ABCC1, derive energy from ATP and 
transport specific substrates to maintain basal ovarian function.  PI3K is an intracellular 
signaling pathway that regulates folliculogenesis, steroidogenesis and chemical 
biotransformation genes.  In this thesis, we hypothesize that ABCB1 and ABCC1 function 
are involved in the ovarian mechanistic response to PM exposure, and that they are 
regulated by the PI3K pathway (Chapter 2).  We also hypothesize that HS alters SULT1E1 
and ABCC1 levels substrate binding thereby impacting E2 as a response to our previously 
observed effects of HS on steroidogenic signaling (Chapter 3).  With a steady increase in 
numbers of female cancer survivors, the fate of their oocyte viability and reproduction is 
important to ensure quality life of these women.  Additionally, as global temperatures rise, 
HS has become a major concern and has had a huge impact on livestock production 
resulting in economic loss.  Therefore, understanding negative influences on ovarian 
function is imperative.   
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Figure 1.1.  Overview of folliculogenesis.   
Primordial follicles are signaled to grow and develop through primary, secondary, antral 
and pre-ovulatory follicular stages towards ovulation.  Following ovulation, the remaining 
tissue differentiates to become the corpus luteum, which undergoes regression if a 
pregnancy has not been established.  The majority (>99%) of follicles die by the natural 
process of atresia.  Adapted from [71] with copyright permission. 
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Figure 1.2. Histological morphology of cultured postnatal day (PND) 4 ovaries.   
A) Cultured neonatal rodent ovaries contain many primordial follicles, some of which 
begin developing and growing during the culture period to primary and secondary stages.  
B)  Most follicles appear normal with H&E staining, as shown on the left.  Others, 
predominantly in the center of ovaries or following exposures to toxic substances, have a 
shrunken, pyknotic (more red or pink) appearance.  From P.J. Devine with permission. 
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Figure 1.3.  Potential age-related effects of reproductive toxicants in females.   
The impact(s) of reproductive toxicants are partially dependent upon the reproductive 
status of the exposed individual.  In most cases, direct ovarian toxicity can lead to 
premature ovarian failure and infertility (menopause).  Adapted from [71] with copyright 
permission. 
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Figure 1.4.  The hypothalamic-pituitary-gonadal axis 
The primary sex steroid hormones, estrogen (E2) and progesterone (P4), are produced due 
to signaling from the hypothalamus to the anterior pituitary for stimulation of androgen 
production in granulosa (GC) and theca cells (TC).  Briefly, GnRH is produced by the 
hypothalamus and binds to GnRH receptors in the anterior pituitary to signal the release of 
luteinizing hormone (LH) and follicle stimulating hormone (FSH) into the endocrine 
system where they bind respectively to follicular TC and GC receptors.  E2 is produced by 
developing follicles and generates negative feedback on the hypothalamus and anterior 
pituitary.  GC release inhibin to send negative feedback on anterior pituitary inhibiting FSH 
production.  High levels of E2 from dominant pre-ovulatory follicles positively feedback 
to cause the LH surge which is critical for ovulation.  Post-ovulation, corpus lutea (CL) 
form which synthesize and release P4.  P4 has negative feedback on the hypothalamus for 
the suppression of GnRH should pregnancy.  Absence of implantation causes regression of 
CL, thereby inhibiting P4 production and removing the negative feedback of P4 on the 
HPG-axis. 
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Table 1.1.   List of some ovotoxicant chemicals and their impact on ovarian function. 
 
Chemical Small pre-antral follicles Growing follicles Hormone Levels 
Atrazine NE NE EO 
BaP EO PE EO 
BPA EO NE NE 
Cd NE EO EO 
CPA/PM EO EO NE 
DEHP NE EO PE 
DMBA EO EO EO 
Hg EO EO EO 
MEHP NE EO EO 
MXC NE EO EO 
Pb NE NE EO 
VCD EO NE NE 
VCH EO NE NE 
  
Abbreviations:  EO, effect observed; NO, no effect; PE, potential effect. 
 
Chemicals listed:  BaP = benzo(a)pyrene; BPA = bisphenol A; Cd = cadium; CPA/PM = 
cyclophosphamide/phosphoramide mustard; DEHP = di-(2-ethylhexyl) phthalate; DMBA = 
9,10-dimethylbenz(a)anthracene; Hg = mercury; MEHP = mono-(2-ethylhexyl)phthalate; 
MXC = methoxychlor; Pb = lead; VCD = 4-vinylcyclohexene diepoxide; VCH = 4-
vinylcyclohexene. 
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Abstract  
Phosphoramide mustard (PM), the anti-neoplastic and ovotoxic metabolite of 
cyclophosphamide causes ovarian DNA adduct formation and depletion of the finite pool 
of ovarian primordial follicles.  Adenosine triphosphate (ATP) binding cassette drug 
transporters including isoforms B1 (ABCB1) and C1 (ABCC1) contribute to phase III drug 
metabolism by binding to conjugated xenobiotics contributing to their cellular excretion. 
We have demonstrated that phosphatidylinositol-3 kinase (PI3K) signaling regulates 
ovarian phase II drug metabolism enzymes.  We had previously reported PM-induced 
increased mRNA encoding in Abcb1 and Abcc1 in an ex vivo ovarian culture. Therefore, 
we hypothesized that ABCB1 and ABCC1 are involved in the ovarian response to PM 
exposure as a cellular defense mechanism to export the ovotoxicant from the ovary, and 
that they are regulated by PI3K.  Spontaneous immortalized granulosa cells (SIGC) were 
cultured in media containing vehicle control (DMSO) or media containing PM (6 µM) for 
48 h until 80% confluent.  Postnatal day 4 (PND4) ovaries were cultured in media 
containing vehicle control (DMSO) or PM (60 µM) ± LY294002 (20 µM) ± kit ligand (400 
ng/ml) for 4 d.  Ovaries were also collected from adult mice 3 d post-exposure to saline or 
PM (25 mg/kg).    Western blotting was performed to quantify ovarian abundance of 
ABCB1 and ABCC1 and their response to PM exposure.  Immunofluorescence staining 
was utilized to determine ABCB1 and ABCC1 protein localization.  No impact of PM 
exposure were observed on ABCC1 protein abundance in either the SIGC or PND4 ovary 
culture models, but in contrast, ABCB1 protein expression was decreased (P < 0.10) in 
PND4 ovaries exposed to PM.  Both ABCB1 and ABCC1 protein abundance were 
decreased (P < 0.05) substantially in ovaries lacking PI3K signaling.  Surprisingly, PI3K 
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activation via kit ligand treatment had no effect on ABCB1 or ABCC1.  In PND4 ovaries, 
both ABCB1 and ABCC1 were localized to the oocyte cytoplasm.  ABCB1 was localized 
in interstitial tissue, granulosa cells and oocyte in adult mouse ovaries.  As the oocyte 
matured towards ovulation, peri-nuclear and peri-cytoplasmic ABCB1 staining was 
observed. ABCC1 was evident in the oocyte nucleus in PND4 ovaries, but was located in 
interstitial tissue, theca cells and oocyte cytoplasm in adult ovaries.   Pre-ovulatory follicles 
expressed ABCC1 on the oocyte peri-cytoplasmic membrane in CT-treated adult mice, but 
this staining pattern was absent in mice exposed to PM.  These data indicate a critical role 
for PI3K in regulation of ovarian phase III drug transporters, as well as demonstrate that 
the oocyte as well as the vascularized thecal cell layer have the capacity to function in 
phase III drug metabolism.    
  
Keywords: Ovary, Phosphoramide mustard, Phase III chemical metabolism 
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Introduction 
The mammalian ovaries are the female reproductive organs that are responsible for gamete 
(oocyte) production and steroid hormone synthesis.  The right and left ovary are located on 
each side of the uterus within the lower region of the abdomen.  The ovary is endowed with 
follicular structures that consist of an oocyte and surrounding granulosa cells in primordial 
and small primary follicles.  As the follicle matures towards ovulation, multiple layers of 
theca cells are recruited to the follicle and each follicle type serves specific functions based 
on its maturation stage [1-3].  Production and regulation of the sex steroids 17β-estradiol 
(E2), and progesterone (P4) are vital for follicle maturation and maintenance of pregnancy, 
respectively [1, 2, 4-7].  
 
Primordial follicle preservation is important because their destruction is irreversible [8-11].  
The ovary contains a finite primordial follicular pool and depletion of this follicular reserve 
can result in infertility and/or premature ovarian failure (POF) [2].  With the advancement 
of industrial and technological applications, there is concern about the potential harm 
generated from the by-products of these advancements [12].  Approximately 11% of 
women suffer from infertility, which may be due to genetically-induced premature ovarian 
senescence [13, 14], exposure to environmental toxicants, or treatment with chemotherapy 
agents [8, 15].  Mortality rates have declined in female cancer patients who receive 
chemotherapy treatments, resulting in a longer life expectancy from the advancement of 
science and technology.  The major concern for survivors is the quality of life and health 
post-treatment with chemotherapeutic drugs [10, 16-22].  
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Cyclophosphamide (CPA) is a commonly used anti-neoplastic agent that is bioactivated to 
phosphoramide mustard (PM) to treat a range of cancers and autoimmune diseases [23, 
24].  Bioactivation of CPA to PM requires the hepatic cytochrome P450 (CYP) enzymatic 
isoforms 3A and 2B [25].  CPA and PM can spontaneously transform into a volatile 
compound, chloroethylaziridine (CEZ), which has cytotoxic characteristics [26-28], 
making it a potential threat for those who work with chemotherapy patients or those who 
are around individuals receiving treatment.  We previously demonstrated that both PM and 
CEZ are ovotoxicants: postnatal day 4 (PND4) cultured rat ovaries exposed to PM (60 µM) 
had a significant decline in numbers of all follicle types after 4 days of treatment [27]. CEZ 
also depleted primordial follicles after 4 days in ovaries that did not have direct 
administration of PM but which were indirectly exposed to CEZ by airborne contact [27].   
 
Phase III chemical metabolism involves drug transporters that excrete and transport both 
foreign and endogenous compounds [29-33]. ATP-binding cassette (ABC) proteins are one 
of the largest transporter protein families characterized in all living organisms [34] and 46 
ABC transporters have been identified in humans [29, 32, 35].  ABC proteins have the 
ability to derive energy from ATP hydrolysis for three important functions: 1) to drive 
transmembrane movement of specific substrates, 2) regulate penetrability of multi-channel 
complexes, and 3) open or close certain membrane channels [36].  The most studied ABC 
transporters are the multi-drug resistance protein (MDR1/ABCB1), also known as p-
glycoprotein, and the multi-drug resistance associated protein (MRP1/ABCC1) [36].  
ABCB1 was the first membrane transporter discovered to play a role in conferring 
multidrug resistance to cancer cells thereby enabling their evasion of anti-neoplastic 
36 
 
chemotherapy treatment such as CPA [37-40].  ABCB1 is approximately 170 kDa in size 
(Higgins, 1992; Croop, 1993; Gottesman, 2002) and transports positively charged or 
uncharged hydrophobic compounds that have been made water soluble by an oxidation 
process that involves CYP 450 enzymes, conjugation to glutathione (GSH), or exportation 
before entrance into the cytoplasm [41].  ABCB1 is localized in the plasma membrane of 
the apical/luminal membrane in polarized cells, endothelial cells of the blood-brain barrier, 
luminal membrane of renal proximal tubule epithelial cells, as well as hepatocyte biliary 
cananlicular and brush border membranes [39, 42-44].   
 
Similar to ABCB1, ABCC1 also promotes a multidrug resistance phenotype to cancer cells 
[45-51].  ABCC1 is approximately 190 kDa in size and transports organic anions, 
hydrophobic compounds, sulfates, glucuronates, 17β-glucuronosyl estradiol, 
bisglucuronosyl bilirubin, and conjugated GSH substrates [36].  A major function of 
ABCC1 is the transport of leukotriene C4 (LTC4) [36].   ABCC1 is typically localized in 
polarized cells of the basolateral membrane, has ubiquitous expression and is specifically 
elevated in the testis and lung [29, 36].   
 
We and others have demonstrated that the ovary has the capacity for phase I [52-54] and 
phase II [55-61] chemical metabolism.  We have also discovered that both the xenobiotic 
biotransformation enzymes transcriptional regulators, arylhydrocarbon receptor (AHR) 
and nuclear factor erythroid-related factor 2 (NRF2), as well as phase I (microsomal 
epoxide hydrolase (EPHX1)) and phase II (Glutathione S-transferase isoforms pi (GSTP) 
and mu (GSTM)) enzymes are downstream of the phosphatidylinositol-3 kinase (PI3K) 
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pathway [55, 57].  Indeed, inhibition of PI3K prevented ovotoxicity induced by 4-
vinylcyclohexene diepoxide (VCD) but accelerated that of dimethylbenz[a]anthracene 
(DMBA) [62], potentially due to increased EPHX1 [57].  Although the basal function of 
ovarian ABCB1 and ABCC1 have not been well characterized, considering their function 
in non-ovarian tissues, their necessity in phase III chemical metabolism for intracellular 
protection of the ovary seems logical.  In addition, in light of ABCB1 and ABCC1 
involvement in conferring resistance to CPA upon cancer cells, the potential for their 
involvement in a defense mechanism protecting non-cancerous cells could be beneficial 
for preservation of the ovary from the cytotoxic effects of CPA and PM.  In this study, we 
hypothesized that ovarian ABCB1 and ABCC1 are involved in the ovarian protective 
response against PM exposure and PI3K is involved in their regulation.   
 
Materials and Methods 
Chemical Reagents  
Phosphoramide Mustard (PM) was obtained from the National Cancer Institute (Bethesda, 
MD).   Tris  base, 2-β-mercaptoethanol, Glycine, Sodium Dodecyl Sulfate, Sodium 
Chloride, Tris Hydrochloric  Acid, tween-20,  Sodium Acetate, Bis- 2-chloroethylamine 
hydrochloride, Bovine Serum Albumin and Ammonium Persulphate were purchased from 
Sigma-Aldrich Incorporated (St. Louis, MO).   Ponceau S Stain was purchased from Fisher 
Scientific and Mini-PROTEAN TGX Gels were obtained from Bio-Rad (Philadelphia, 
PA).  RNeasy Mini Elute kit, RNeasy mini kit, QuantitectTM SYBR Green PCR kit and 
QIA shredder kit were purchased from Qiagen Incorporated (Valencia, CA).  EDTA, 
Pen/Strep, Fetal Bovine Serum, 1X Dulbeco’s Modified Eagle Medium and 10X phosphate 
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buffered saline were purchased from Life Technologies (Grand Island, NY).  Corning 
storage system/vacuum filter and cell culture flasks were obtained from Corning 
Incorporated (Corning, NY).   Clear nail polish was obtained from Electron Microscopy 
Sciences (Hatfield, PA). X-ray film was purchased from Thermo Scientific (Rockford, IL) 
and SignalFire ECL western detection reagents were purchased from Cell Signaling 
Technologies (Beverly, MA).  Recombinant mouse kit ligand was obtained from R & D 
Systems Inc. (Minneapolis, MN). LY294002 was purchased from A.G. Scientific, Inc. (San 
Diego, CA).  Primary antibodies were purchased from Cell Signaling (Beverly, MA) and 
secondary antibodies were purchased from Southern Biotech (Birmingham, AL).  
 
Rat spontaneously immortalized granulosa cell culture 
The rat spontaneously immortalized granulosa cell (SIGC) line was received from Dr. 
Robert Burghardt at Texas A&M University.  SIGC cells were cultured in 25cm2 flasks in 
media containing DMEM/F12, 50mg/ml Pen Strep, and 5% FBS media until 80% 
confluent at 37OC and 5% CO2.  Cells were treated with vehicle control (1% DMSO) or 
PM (6 µM) for 48 h for protein isolation.  This PM concentration and time point was 
previously demonstrated to cause approximately 30% cell death [63].   
 
Postnatal day 4 (PND4) ovary culture   
PND4 female Fisher 344 rat ovaries (n=3; 10 ovaries per pool) were excised, trimmed of 
excess tissue and placed onto a membrane floating on 250 µl of 1X DMEM nutrient 
mixture-F-12(Ham) media containing 1 mg/ml Albumax, 1 mg/ml BSA, 5 U/ml penicillin, 
50 µg/ml ascorbic acid, and 27.5 µg/ml transferrin.  Ovaries were cultured in vehicle 
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control (1% DMSO) or PM (60 µM) or LY294002 (20 µM) or kit ligand (400 ng/ml) at 
37OC with 5% CO2 for 4 d and the media was changed on alternate days.  PM treated 
ovaries were placed in a separate incubator from the control treated ovaries in order to 
prevent contamination from the ovotoxic volatile compound chloroethylaziridine (CEZ) 
which is spontaneously liberated from PM [27].  This concentration and time of PM 
exposure were previously shown to induce follicle loss in the cultured ovarian system [27].  
This procedure was approved by the Institutional Animal Care and Use Committee at Iowa 
State University.  
 
In vivo PM exposure and ovary collection 
Adult female mice (15 wks) (n=5) were intraperitoneally (i.p) dosed once with sesame oil 
(SO) or PM (95%; 25mg/kg). This dose was chosen based on the literature [64, 65].  Mice 
were euthanized 3 days after the end of dosing in their pro-estrus phase.   
 
Protein isolation and western blotting 
Following culture, SIGC cells or PND4 cultured ovaries were processed for total protein 
isolation by homogenization and placing on ice for 30 min.  Samples were centrifuged at 
10,000 rpm for 15 min (2X) at 4°C followed by collection of supernatant.  Protein 
concentration was quantified with a ND-1000 Spectrophotometer (λ = 260/280 nm; 
NanoDrop technologies, Inc., Wilmington, DE).  Proteins were separated by SDS-PAGE 
followed by a 13 minute dry transfer using an iBlot 2 (Life Technologies).  Membranes 
were blocked for 3 h in 5% BSA in phosphate buffered saline containing Tween 20.  
Membrane was then incubated for 48 h in anti-ABCC1 (1:100 dilution) or anti-ABCB1 
(1:100 dilution) at 4°C.  Following 3 washes with 1x PBST, membranes were incubated in 
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a goat anti-rabbit-HRP (1:2000 dilution) secondary antibody for 1 h at room temperature, 
followed by 3 washes in PBST for 10 minutes each.  Membranes were incubated in 
enhanced chemiluminescence (ECL) reagent for 10 minutes and exposed to X-ray film.  
Densitometry of the appropriate bands was performed using ImageJ software (NCBI). 
Chemical exposures can impact traditional housekeeping protein abundance (our 
unpublished data), thus equal protein loading was confirmed by Ponceau S staining of total 
protein and protein level was normalized to Ponceau S densitometry values.  Negative 
controls used were primary only ABCC1/ABCB1 (1:100), secondary only goat anti-rabbit-
HRP (1:2000), and normal goat IgG primary (1:100) with goat anti-rabbit-HRP secondary 
(1:2000).   
 
Immunofluorescence staining 
Ovaries were fixed in paraformaldehyde (4%) for 2 h (PND4 cultured rat ovaries) or 24 h 
(adult mouse ovaries), transferred to 70% ethanol, embedded in paraffin followed by serial 
sectioning of 5 μM thick sections and every 10th section mounted onto slides.  Slides were 
deparaffinized in citrisolv 3 times for 8 min each and rehydrated with washes in serial 
dilutions of 100, 80, 70, and 50 percent ethanol  (8 min per wash) followed by one wash 
with ddH20.  Antigen retrieval was performed by microwaving slides in sodium citrate and 
citric acid solution (1 M, Ph 6.0) for 10 min.  Sections were circled with a PAP pen and 
washed once in ddH20 followed by a single wash with 1X TBST for 10 min.  Slides were 
then blocked (5% normal goat serum in TBST) for 1 h at room temperature followed by 
incubation with a primary antibody directed against ABCC1 (1:25 dilution) or ABCB1 
(1:200 dilution) overnight at 4°C.  Slides were washed 3X with 1X TBST for 10 min each 
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followed by incubation in goat anti-rabbit- IgG (H+L) FITC secondary antibody (1:200 
ABCC1 and 1:500 ABCB1 dilution) at room temperature followed by 3 washes with 1X 
TBST.  Slides were counterstained with SlowFade Gold antifade reagent with 4-6-
diamifino-2-phenylindole (DAPI) and sealed with microscope cover slips with clear nail 
polish.  Slides were allowed to dry for 30 min prior to imaging.   Images were captured at 
10X and 40X magnification with a Leica fluorescent microscope.   
 
Statistical analysis 
Paired 1-tailed t-test comparisons were used to compare control treated and PM exposed 
cultured ovaries. Unpaired 1-tailed t-test comparisons were used to compare control and 
PM treated spontaneously immortalized granulosa cell line cell culture. One-way ANOVA 
analysis to compare ovarian endpoints from control, LY294002, and Kit-Ligand treated 
cultured ovaries followed by further analysis by Tukey’s Multiple Comparison test 
between all 3 treatment types. Statistical significance was considered if the P-value was 
less than 0.05.  A trend towards a biologically significant change was considered at P < 
0.1.    
 
Results 
PM exposure did not impact ABCC1 protein abundance in granulosa cells 
ABCC1 was abundant in total protein homogenates from cultured spontaneously 
immortalized granulosa cell line, but PM exposure did not impact (P = 0.16) the abundance 
of ABCC1 (Figure 2.1).   
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 PM exposure did not alter ABCC1 protein abundance in cultured whole ovaries  
Total ovarian protein homogenate contained ABCC1 protein; however, no impact (P = 
0.49) of PM exposure on total ovarian ABCC1 protein level was observed (Figure 2.2).   
 
Ovarian ABCB1 is decreased by PM exposure 
Total ovarian protein homogenate from cultured neonatal rat ovaries was abundant in 
ABCB1 protein.  Interestingly, the protein abundance of ABCB1 was decreased (P = 0.05) 
by PM exposure at the time of follicle loss which occurs at day 4 (Figure 2.3).  
 
ABCC1 protein is reduced by inhibition of PI3K signaling 
Utilizing protein isolated from ovaries cultured in media containing the PI3K inhibitor, 
LY294002 (20 µM) or the PI3K activator, Kit Ligand, western blotting demonstrated that 
in the absence of PI3K, ABCC1 protein was essentially absent (P = 0.03) from the ovary 
compared to control treatment (Figure 2.4). Interestingly, Kit Ligand treatment, did not 
impact ABCC1 protein levels and no difference (P = 0.15) from control treated ovaries 
was observed (Figure 2.4).   
 
ABCB1 protein is reduced by absence of PI3K signaling 
Similarly to ABCC1, lack of PI3K signaling in cultured ovaries reduced (P = 0.03) ABCB1 
protein abundance, though to a lesser extent than that of ABCC1 (Figure 2.5).  Kit Ligand 
treatment had no impact of ABCB1 protein abundance (P = 0.16) (Figure 2.5).  
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ABCC1 localization in the ovary and impact of PM exposure 
ABCC1 was localized in the nucleus of the oocyte in pre-antral follicles (Figure 2.6A,B) 
and increased expression observed in growing follicles with CT and PM treatments (Figure 
2.6A,B).  The adult mouse ovary expressed ABCC1 in the oocyte nucleus, interstitial 
tissue, and oocyte cytoplasm (Figure 2.6C).  Maturing oocytes expressed ABCC1 on their 
oocyte peri-cytoplasmic and peri-nuclear membrane in the CT treatment mice, but this was 
ablated by PM treatment treated (Figure 2.6D).   
 
 Ovarian localization and impact of PM exposure on ovarian ABCB1  
ABCB1 is localized to the oocyte cytoplasm in pre-antral follicles (Figure 2.7A-D).  
Interestingly, increased PM-induced ABCB1 was observed as follicles matured (Figure 
2.7D).  In the adult mouse ovary, ABCB1 was localized to the interstitial tissue, to the 
granulosa cells and the oocyte (Figure 2.7E, F).  As the oocyte matured towards ovulation, 
peri-nuclear and peri-cytoplasmic ABCB1 staining was observed (Figure 2.7G).  
 
Discussion 
The primordial follicular pool is vital for female fertility preservation.  Disruption of 
follicular development by exogenous chemical compounds can lead to early senescence of 
the ovary [8].  Previous studies have shown that CPA induced ovotoxicity in mice and rats 
and depleted follicles by targeting granulosa cells [66]. We have previously demonstrated 
that CPA, and its ovotoxic metabolite, PM, induce both primordial and small primary 
follicle loss.  PM is known to spontaneously transform into a cytotoxic volatile compound, 
CEZ, which also depletes primordial follicles [27].  ABCB1 and ABCC1 were discovered 
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on the basis of drug resistance to chemotherapy agents in tumors and therefore could 
encompass potential roles in conservation of the ovary [36].  We hypothesized that phase 
III chemical metabolism involving ABCB1 and ABCC1 may be an important factor for 
protection of the ovary during PM exposure and that ABCB1 and ABCC1 are regulated 
via the PI3K pathway as we have previously observed with Phase I and II chemical 
biotransformation proteins [55, 57].  
 
ABCB1 regulates a detoxification process by oxidation via CYP 450 enzymes making 
hydrophobic compounds water soluble [37, 38, 40, 67].   Though CPA is activated in 
tumors via CYP450 enzymatic activity, its inactivation can be induced by overexpression 
of CYP450 enzymes [68-74].  Dhaini et al. (2003) demonstrated that increased levels of 
CYP3A in osteosarcoma tumors of patients resulted in metastasis and poor prognosis 
confirming that drug efficacy of CPA was altered due to drug metabolizing enzymes [70].  
Thus, ABCB1 and ABCC1 could be key factors in understanding potential ovarian 
protective properties in non-cancer cells induced by CPA and PM toxicity.   PM exposure 
to spontaneous immortalized granulosa cells and cultured whole ovaries did not alter 
ABCC1 protein expression, but did, however, decrease ABCB1 protein abundance in 
PND4 rat ovaries.  ABCC1 protein abundance may not have been altered by PM exposure 
because of its substrate specificity for GSH conjugates instead of CYP 450 enzymatic 
activity, which is vital for CPA’s bioactivation [51].   
 
The PI3K pathway promotes primordial follicle recruitment and viability in the ovary [75-
78].  PI3K activation is regulated by the binding of kit ligand produced by granulosa cells 
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to the oocyte receptor c-Kit [79-82].  We have previously demonstrated that PI3K 
inhibition altered ovotoxicity caused by VCD and DMBA [62, 83].  Inhibition of PI3K 
completely prevented VCD-induced depletion of primordial follicles but accelerated that 
induced by DMBA, to such an extent that essentially no primordial follicle oocytes could 
be identified [62]. We concluded that VCD caused hyperactivation of the primordial 
follicle pool as an ovotoxicant mechanism [62].  We also attributed these effects to PI3K 
mediated regulation of EPHX1 protein in the ovary; EPHX1 detoxifies VCD [57] and 
bioactivates DMBA [83], thus regulation of chemical metabolism enzymes contributes 
dramatically to resulting ovotoxicity.  We therefore interrogated whether ABCB1 and 
ABCC1 were also regulated via PI3K.  Xie et al. (2013) revealed that expression of ABCB1 
was down regulated with PI3K inhibition in gastric cancer cells and there was upregulated 
expression of pro-apoptotic Caspase-3 and Bax [84].  A clinical study by Imai et al., 
demonstrated that LY294002 promoted inhibition of ABCC1 in human stem cells via 
competitive inhibition and alteration of protein expression [85].  Cultured PND4 rat ovaries 
treated with LY294002 resulted in nearly the complete absence of ABCC1 protein levels, 
but surprisingly, this effect was not impacted by kit ligand treatment.  Similar to ABCC1, 
ABCB1 protein expression significantly decreased with inhibition of PI3K and yet again 
no impact of kit ligand treatment was observed.  Thus, similar to our previous findings that 
suggest that NRF2, EPHX1, GSTM, GSTP, and AHR are downstream of the PI3K pathway 
[55, 57], these data support that ABCC1 and ABCB1 are regulated by PI3K.  Lack of any 
effect of kit ligand to overcome the impact of PI3K deficiency on ABCB1 and ABCC1 is 
an area for further investigation and may yield insight into specific regulators of these 
phase III drug transporters.   
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Investigations of porcine and starfish oocytes and somatic cells have demonstrated 
increased ABCB1 expression concomitant with follicle maturation [86-89]. Further, it was 
shown that ABCB1 abundance in human and mouse follicles exhibited conflicting results 
at a transcriptional level compared to the translational level.  The study found that 
transcriptionally, Abcb1 was increased in Meiosis II (MII) compared to germinal vesicle 
(GV) phase oocytes, but ABCB1 protein was decreased in MII possibly indicating that MII 
oocyte ABCB1 expression is stored for later use [86].  Following treatment with PM, we 
determined that ABCB1 was localized to the oocyte cytoplasm of pre-antral follicles in 
cultured PND4 rat ovaries and observed increased ABCB1 expression in growing follicles.  
Adult female mice were treated with PM and ABCB1 was detected in interstitial tissue, 
granulosa cells, oocyte, and peri-nuclear and peri-cytoplasm structure of the pre-ovulatory 
follicle.  Our findings also suggest that ABCB1 function and expression is expressed in 
different follicle stages dependent on the developmental stage of the female, since we 
observed differential locations in postnatal relative to adult ovaries.   
 
ABCC1 was detected in the peri-nuclear membrane of cadmium resistant RH460 lung 
cancer cells but migrated to the cytoplasmic compartment following cadmium exposure 
[90].  Our findings demonstrated that ABCC1 was localized in the peri-nuclear region of 
adult mice pre-ovulatory follicles in control treated mice, but this staining pattern was not 
obvious in PM exposed ovaries.  Redistribution of ABCC1 from the peri-nuclear 
membrane may have been due to PM-induced follicular damage.  ABCC1 was also 
localized in interstitial tissue, oocyte nucleus and cytoplasm.  A different localization 
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pattern from adult ovaries was observed in neonatal ovaries in which ABCC1 was localized 
mainly in the oocyte nucleus of and reduced by PM exposure.  These data are novel since 
information regarding ABCC1 expression and function in different follicular 
developmental stages in the ovary are not well informed and require further investigation.   
 
CPA is often used as a treatment for autoimmune diseases since it induces 
immunosuppression by inhibiting immune suppressor cells [23].  Tumor cells can elicit an 
immune response in a mechanism known as immune-editing that renders the cancerous 
cells non-detectable by the immune system [91].  We noted the appearance of cellular 
structures in the PM-treated ovary that may represent immune cell infiltration, as their 
appearance was localized to atretic follicles.  Whether the immune system is participating 
in clearing cellular debris post-PM exposure remains to be confirmed.    
 
In summary, this is the first study investigating ovarian expression of ABCB1 and ABCC1 
during PM exposure and we have demonstrated the novel finding that these phase III drug 
transporters are downstream of PI3K signaling.  Considering that depletion of primordial 
follicles and POF induction result in a longer time frame spent post-menopause, better 
understanding of proteins involved in the ovarian protective response to ovotoxicants is 
needed. Also, the importance of understanding the mechanistic pathways and regulation of 
two key drug transporters, ABCC1 and ABCB1, in response to CPA, which is commonly 
used for female cancers, could both decrease the mortality rates and improve reproductive 
function post-treatment.  In addition, since ovarian cancer is a “silent” cancer with high 
chemoresistance and poor prognosis [92], better understanding of the function of ovarian 
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phase III drug transporters would further our knowledge in this area of female reproductive 
health.   
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Chapter 2 Figures 
 
 
Figure 2.1.  Impact of PM exposure on ABCC1 abundance in SIGC.  SIGC were 
cultured in media containing vehicle control (CT; DMSO) or PM (6 µM) for 48 h.  Total 
protein was isolated and ABCC1 protein abundance determined by western blotting.  
Barchart indicates relative densitometric values for ABCC1 protein in CT (C)- or PM (P)-
treated cells; values represent mean ± standard error (n = 3 per treatment); Difference 
between treatments; P = 0.16.   
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Figure 2.2.  Effect of PM treatment on ABCC1 protein abundance in neonatal 
cultured ovaries.  PND4 ovaries were cultured for 4 d in media containing vehicle control 
(CT; DMSO) or PM (60 µM).  Total protein was isolated and western blotting performed 
to quantify ABCC1 protein abundance.  Barchart indicates relative densitometric values 
for ABCC1 protein in CT (C)- or PM (P)-treated cells; values represent mean ± standard 
error (n = 3 pools per treatment; 10 ovaries per pool); Difference between treatments; P = 
0.49. 
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Figure 2.3.  Impact of PM exposure on ABCB1 protein in cultured whole ovaries.   
PND4 ovaries were cultured for 4 d in media containing vehicle control (CT; DMSO) or 
PM (60 µM).  Total protein was isolated and western blotting performed to quantify 
ABCB1 protein abundance.  Barchart indicates relative densitometric values for ABCB1 
protein in CT (C)- or PM (P)-treated cells; values represent mean ± standard error (n = 3 
pools per treatment; 10 ovaries per pool).  † indicates difference between treatments; 
Difference between treatments; P =0.05.  
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Figure 2.4.  Effect of PI3K inhibition on ABCC1 ovarian protein level.  
PND4 ovaries were cultured in media containing vehicle control, LY294002 (LY; 20 µM) 
or kit ligand (KL; 400 ng/ml)) for 4 d.  Total protein was isolated and ABCC1 protein 
abundance determined by western blotting.  Barchart indicates relative densitometric 
values for ABCC1 protein in CT- LY- or KL-treated cells; values represent mean ± 
standard error (n = 3 pools per treatment; 10 ovaries per pool).  * indicates difference 
between treatments; P = 0.03.     
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Figure 2.5.  ABCB1 protein is reduced by absence of PI3K signaling. 
PND4 ovaries were cultured in media containing vehicle control, LY294002 (LY; 20 µM) 
or kit ligand (KL; 400 ng/ml)) for 4 d.  Total protein was isolated and ABCB1 protein 
abundance determined by western blotting.  Barchart indicates relative densitometric 
values for ABCB1 protein in CT- LY- or KL-treated cells; values represent mean ± 
standard error (n = 3 pools per treatment; 10 ovaries per pool).  * indicates difference 
between treatments; P = 0.03.   
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Figure 2.6.  Ovarian localization and effect of PM exposure on ovarian ABCC1.  
Immunofluorescence staining to localize ABCC1 (red staining) was performed on fixed 
ovarian sections of (A,B) cultured PND4 ovaries treated with media containing vehicle 
control (A) or PM (60 µM; B) for 4 d.  Additionally, ovarian sections from adult mice 
treated with vehicle control (saline; C)) or PM (25 mg/kg; intraperitoneal injection; D) 
were stained to localize ABCC1 (red staining).  DNA was stained with DAPI (blue 
staining) to localized cell nuclei.  Primordial follicles are indicated with a chevron; arrow 
= small primary follicles; arrowhead = theca cell layer; broken arrow = pericytoplasmic 
oocyte membrane.  Scalebar = 25 microns. 
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Figure 2.7.  Ovarian localization and impact of PM exposure on ovarian ABCB1. 
Immunofluorescence staining to localize ABCB1 (red staining) was performed on fixed 
ovarian sections of (A-D) cultured PND4 ovaries treated with media containing vehicle 
control (A, C) or PM (60 µM; B, D) for 4 d.  Additionally, ovarian sections from adult 
mice treated with vehicle control (saline; E)) or PM (25 mg/kg; intraperitoneal injection; 
F, G, H) were stained to localize ABCB1 (red staining).  DNA was stained with DAPI (blue 
staining) to localized cell nuclei.  Primordial follicles are indicated with a chevron; arrow 
= small primary follicles; arrowhead = pre-ovulatory oocyte; broken arrow = infiltrating 
immune cells.  Scalebar = 25 microns.   
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Abstract 
 
The ovary consists of germ and somatic cells whose major functions are gamete and steroid 
hormone production, respectively.  The anatomy of the porcine and human female 
reproductive tracts are closely related and both are regulated by the hypothalamic-pituitary-
gonadal axis.  HS has a major impact on the productivity of livestock agriculture in the US.  
Our previous studies demonstrated that HS disrupts ovarian steroidogenic signaling 
potentially altering ovarian function in the heat-stressed pig.  The sulfotransferase, 
SULT1E1, catalyzes 17β-estradiol sulfonation.  ABCC1, an ABC cellular transporter, 
exports and imports GSH, organic anions, and sulfate conjugated substrates, including 
sulfonated 17β-estradiol.  We hypothesized that HS could affect the abundance of both 
SULT1E1 and ABCC1, thereby impacting ovarian 17β-estradiol and precipitating altered 
steroidogenic signaling in response.    Three models of HS were utilized: pre-pubertal gilts 
were heat stressed for 7 (n = 5 per treatment) or 35 (n = 3 per treatment) days.  Also, post-
pubertal gilts were estrus synchronized followed by 5 d of HS during the follicular phase.  
Chronic HS for 35 d of exposure in pre-pubertal gilts increased (P < 0.05) both ABCC1 
and SULT1E1 protein expression, without any alteration observed in ABCC1 mRNA.  HS 
in post-pubertal gilts did not have an impact on ABCC1 mRNA or protein level, but 
increased SULT1E1 protein abundance.  Our data support that ABCC1 and SULT1E1 are 
at a high level in the porcine ovary and that both proteins are potentially involved in altering 
the ovarian level of 17β-estradiol and can be affected by HS.    
 
Keywords:  Ovary, Heat Stress, 17β-estradiol, phase III metabolism 
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Introduction 
 
The general female reproductive system is comprised of oocytes (germ cells) and somatic 
cells, including granulosa, stromal, and thecal cells [1].  The main functions of the female 
reproductive tract are for gamete and steroid hormone production to promote follicular 
development and pregnancy maintenance [2-4].  The anatomy of the porcine reproductive 
tract is similar to that of humans, except it has a bihorned utuerus that fuses into the uterine 
body and urogenital opening.  Porcine reproductive cycles, which are also similar to 
humans, are regulated by the negative/positive feedback of the hypothalamic pituitary 
gonadal axis.  The follicular reserve of the female reproductive tract is limited in that, if 
depleted, it results in early menopause and/or infertility [2].  Regulation of primordial 
follicle recruitment and activation is managed via the phosphatidylinositol-3 kinase (PI3K) 
signaling pathway [5-9].  
 
A secondary major function of the ovary is to produce sex hormones and is one of the 
primary sites for steroidogenesis.  Steroidogenesis includes synthesis of the ovarian 
steroids estrogen and progesterone from the dominant follicles and corpora lutea, 
respectively.  Ovarian hormone synthesis is regulated by cytochrome P450 (CYP) enzymes 
where up-take of cholesterol occurs in the mitochondria, by the action of steroidogenic 
acute regulatory protein (StAR).  Cholesterol is converted into pregnenolone which 
diffuses into the cytoplasm and is converted to progesterone (P4) via the enzyme, 3β-
hydroxysteroid dehydrogenase.  Alternatively, pregnenolone can be converted to 17α-OH-
pregnenolone which is further metabolized into androstenedione and/or testosterone, which 
both can be irreversibly metabolized to estrone and 17β-estradiol by CYP19a.  This 
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hormone synthesis involves follicular theca and granulosa cell structural compartments, 
therefore depends on the interaction between thecal and granulosa cells which is now 
regarded as the two-cell-two gonadotropin theory.  The theca cells express luteinizing 
hormone (LH) receptors which undergo a process for the conversion of cholesterol to 
androgens, which are then migrated to the granulosa cells where follicle stimulating 
hormone (FSH) regulates estrone and 17β-estradiol production [10].   
 
Heat stress (HS) is a biological response to high core body temperature that serves as a 
threat to its homeostatic properties [11-14].  HS is an environmental stressor resulting from 
high ambient temperatures that impacts agriculture livestock production limiting the 
manufacturing of high grade quality protein [11]. Pigs have low tolerance for HS since they 
lack functional sweat glands.  HS disrupts the development and function of mammalian 
reproduction by impairing hormone production secretions, embryo development [15, 16], 
ovarian folliculogenesis [16, 17], and uterine environment [18, 19].  Studies have reported 
seasonal infertility, reduced implantation rates, impairment of embryo development, and 
altered ovarian activity related to HS in gilts and sows [14, 20-22].  Similar findings have 
been found in boars where total sperm counts were reduced and an increase in percentage 
of abnormal spermatozoa post-HS [23].  Zeng et al. demonstrated alterations of 
microfilaments and microtubules in the porcine oocyte during in vitro maturation, 
increased apoptosis, and low developmental proficiency due to HS exposure [15].  Our 
previous studies demonstrated activation of insulin signaling pathway members during HS 
exposure which included increased abundance of the PI3K members, AKT1 and FOXO3, 
at mRNA levels in pre-pubertal gilt ovaries [24].  We also demonstrated that steroid 
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hormone production genes and proteins were altered by HS.  LDLR, LHCGR, and CYP19a 
mRNA abundance were increased after 7 d of HS and STAR was increased after 35 d of 
HS.  Additionally, CYP19a protein levels increased following 7 d and 35 d of HS [24].  
These findings suggest that HS could be associated with early primordial follicle activation, 
increased apoptosis, and impaired steroidogenesis [24].   
 
ATP-binding cassette (ABC) transporters are involved in the ATP-dependent import or 
export and a variety of external compounds and endogenous substrates.  Multidrug 
resistance associated protein (MRP1), also known as ABCC1, is part of the ABC 
transporter family that transports organic anions and glutathione (GSH), glucoronate, and 
sulfate conjugated substrates [25]. It is expressed in most tissues and localized in polarized 
cells of the basolateral membrane [25]. Sulfotransferases are known to be involved in phase 
II drug metabolism [26].  Estrogen sulfotransferase (SULT1E1) is a cytosolic enzyme that 
catalyzes estrogen sulfonation [26, 27].  In humans, it has a high affinity for catalyzing the 
sulfoconjugation of estradiol and estrone at the 3-hydroxyl terminal [26]. It is also present 
in the porcine uterine endometrium and recent studies have demonstrated increased 
SULT1E1 gene expression observed at day 12 of pregnancy, but persisting at low levels 
throughout the rest of the gestational term [28].  This enzyme has also been demonstrated 
to affect tumorigenesis in estrogen-dependent cancers [26].  Free estrogens are biologically 
active and become inactive when conjugated [29].  Regulation of estrogen levels 
throughout the estrous cycle are important and rely on the activity of CYP19a, 17β-HSD, 
and SULT1E1 among others [26]. Cole et al, demonstrated that ABCC1 requires GSH for 
binding of estrone sulfate [30].  Low activity of SULT1E1 have been reported in the boar 
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testis [31].  Based upon our previous findings, we hypothesized that HS could affect both 
SULT1E1 and ABCC1, thereby altering ovarian 17β-estradiol level.  Though not 
previously classified in the porcine ovary, we proposed in this study that SULTE1 enzyme 
catalyzes sulfonation-mediated inactivation of 17β-estradiol, followed by transport from 
the ovary by the drug transporter protein ABCC1.   
 
Materials and Methods 
Reagents 
Tris  base, 2-β-mercaptoethanol, Glycine, Sodium Dodecyl Sulfate, Sodium Chloride, Tris 
Hydrochloric  Acid, tween-20,  Sodium Acetate, Bis- 2-chloroethylamine hydrochloride, 
Bovine Serum Albumin and Ammonium Persulphate were purchased from Sigma-Aldrich 
Incorporated (St. Louis, MO).   Ponceau S Stain was purchased from Fisher Scientific and 
Mini-PROTEAN TGX Gels were obtained from Bio-Rad (Philadelphia, PA).  RNeasy 
Mini Elute kit, RNeasy mini kit, QuantitectTM SYBR Green PCR kit and QIA shredder kit 
were purchased from Qiagen Incorporated (Valencia, CA).  The SULT1E1 H-40 primary 
antibody was purchased from Santa Cruz (Santa Cruz, CA).  Goat anti-Rabbit-HRP 
secondary antibody was purchased from Southern Biotech (Birmingham, AL). SignalFire 
ECL western detection reagents purchased from Cell Signaling Technologies (Beverly, 
MA) and Xray Film was purchased from Thermo Scientific (Rockford, IL).   Primary 
antibody, ABCC1, was purchased from Cell Signaling (Beverly, MA).  
 
 
 
 
67 
 
Animal Experiments and tissue collection 
Pre-pubertal gilt experiment   
Tissues analyzed in this manuscript were obtained as a subset from previous experiments 
with all procedures approved by the Iowa State University Institutional Animal Care and 
Use Committee.  Details regarding experimental design, animal handling and 
environmental conditions have been previously described [32-34].  In brief, crossbred pre-
pubertal gilts (35 ± 4 kg) were housed in constant climate controlled rooms in individual 
pens with ad libitum feed intake. Gilts were exposed to thermoneutral (TN) conditions 
(20°C; 35-50% humidity; n = 5-6) or HS conditions (35°C; 20-35% humidity; n = 5-6) for 
7 (n = 5 per treatment) or 35 (n = 3 per treatment) days. To eliminate the effects of 
dissimilar feed intake, an additional group of thermoneutral gilts (n = 3) were pair-fed to 
the HS treatment for 7 d (PFTN).  Gilts were euthanized by captive bolt penetration, one 
ovary was snap frozen in liquid nitrogen and stored at -80oC and the contralateral ovary 
was fixed in 4% paraformaldehyde.   
 
Post-pubertal gilt experiment 
Procedures were approved by the Iowa State University Institutional Animal Care and Use 
Committee.  Pubertal gilts (n = 12; 126.02 ± 21.6 kg) were synchronized to the estrus phase 
through Matrix® feeding 14 days.  On the day after Matrix® withdrawal gilts were exposed 
to TN (n = 6, 20.3°C ± 0.1°C) or HS (n = 6, 26-32°C) conditions for 5 d during the follicular 
phase.  Humidity was recorded during the study period as 33 ± 13% in the TN room and 
24 ± 6% in the heat stressed room.  Rectal temperature was recorded as 38.68oC in the TN 
animals and 39.48oC in the HS gilts.   All gilts were limit fed (6 lbs per day), thus no 
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dissimilar feed intake levels were present.  Gilts were euthanized by captive bolt 
penetration, follicular fluid was captured from all dominant follicles and pooled for 17β-
estradiol measurement.  One ovary was snap frozen in liquid nitrogen and stored at -80oC 
and the other ovary was fixed in 4% paraformaldehyde.   
 
 
 
RNA Isolation and quantitative reverse transcription polymerase chain reaction (qRT-
PCR) 
Ovaries were crushed in liquid nitrogen until in powdered form using a hand mortar and 
pestle.  Total RNA was extracted using an RNeasy Mini kit and RNeasy Mini Elute kit 
following manufacturer’s protocols and eluted in 14 µl RNase–free water.  RNA 
concentration was measured with ND-1000 Spectrophotometer (λ = 260/280 nm; 
NanoDrop technologies, Inc., Wilmington, DE).  Total RNA was reverse transcribed into 
cDNA with master mix of Superscript III, 1st Strand Buffer, DTT, and RNAse Out® 
followed by thermocycler incubation at 50oC for 60 min and 70oC for 15 min.  cDNA (2 
µl; 1:10 dilution) was amplified using ABCC1 primers on an Eppendorf Mastercycler using 
a Quantitect SYBR Green PCR kit.  Primer design was generated from the NCBI primer 
blast database (forward primer: 5’-TTTACTTCGCCCTCGTGCTG-3’; Reverse primer: 
5’-GGGCAAGGATTAGGGTCGTG-3’).  Glyceraldehyde 3-phosphaste dehydrogenase 
(GAPDH) was used as the endogenous control for normalization.  The cycling program 
consisted of a 15 min hold at 95°C and 50 cycles of: denaturing at 95°C for 15 sec, 
annealing at 60.6°C for 15 sec, and extension at 72°C for 20 sec.  Technical controls 
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included omission of template (cDNA), forward/reverse primers and master mix only, and 
H2O.  Relative fold change was determined using 2-ΔΔCT method. The relative fold 
change was calculated using the 2-∆∆CT method and the results are presented as mean fold 
difference ± standard error relative to the TN control group. 
 
Protein isolation and western blotting 
Total ovarian protein was isolated by powdering frozen ovaries with a mortar and pestle, 
followed by homogenization in tissue lysis buffer and placing on ice for 30 min.  Samples 
were centrifuged at 10,000 rpm for 15 min (2X) at 4°C followed by collection of 
supernatant.  Protein concentration was quantified with a ND-1000 Spectrophotometer (λ 
= 260/280 nm; NanoDrop technologies, Inc., Wilmington, DE).  Proteins were separated 
by SDS-PAGE followed by a 13 minute dry transfer using an iBlot 2 (Life Technologies).  
Membranes were blocked for 3 h in 5% BSA in phosphate buffered saline containing 
Tween 20.  Membrane was then incubated for 24 or 48 h in anti-ABCC1 (1:100 dilution) 
or SULT1E1 (1:200), respectively, at 4°C.  Following 3 washes with 1X PBST, membranes 
were incubated in goat anti-rabbit-HRP (1:20,000 dilution) secondary antibody for 1 h at 
room temperature, followed by 3 washes in PBST for 10 minutes each.  Membranes were 
incubated in enhanced chemiluminescence (ECL) reagent for 10 minutes and exposed to 
X-ray film. Negative controls used were primary only SULT1E1, primary only ABCC1, 
secondary only goat anti-rabbit-HRP, and normal goat IgG primary/goat anti-rabbit-HRP 
secondary.    Densitometry of the appropriate bands was performed using ImageJ software 
(NCBI). Chemical exposures can impact traditional endogenous control protein abundance 
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(our unpublished data), thus equal protein loading was confirmed by Ponceau S staining of 
total protein and protein level was normalized to Ponceau S densitometry values. 
 
Statistical analysis 
All data were statistically analyzed using GraphPad Prism software.  Comparison of two 
treatments was performed using unpaired two-tailed t-test; comparison of more than two 
treatments was performed by one-way ANOVA and Tukey’s Multiple Comparisons test 
for difference between treatments.  A P-value < 0.05 was considered significantly different, 
with P < 0.1 considered a trend for a difference.  
 
Results 
Ovarian ABCC1 mRNA or protein abundance not impacted by acute HS in the pre-pubertal 
gilt 
ABCC1 mRNA was detectable in the porcine ovary (Figure 3.1).  There was no impact of 
reduced feed intake on ABCC1 mRNA level.  In addition, HS did not have any effect on 
ovarian ABCC1 in the pre-pubertal gilt (Figure 3.1) (P = 0.44).  ABCC1 protein was also 
abundant in the porcine pre-pubertal ovary, but neither reduced feed intake nor HS 
impacted ABCC1 protein level, relative to the TN control gilts (Figure 3.2) (P = 0.49).    
 
Chronic HS increases ABCC1 protein abundance in the pre-pubertal gilt ovary 
Chronic (35 d) HS did not affect ABCC1 mRNA level in the pre-pubertal gilt ovary (P = 
0.39) (Figure 3.3), however, ovarian ABCC1 protein abundance was increased (P = 0.01) 
by HS (Figure 3.4).   
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Ovarian SULT1E1 abundant in the porcine ovary and increased by chronic HS in pre-
pubertal gilt ovary 
SULT1E1 was detectable in the pre-pubertal gilt ovary albeit at a low level in TN treated 
gilts.  SULT1E1 protein level was increased (P = 0.003) by 35 d of chronic HS (Figure 
3.5). 
 
ABCC1 mRNA or protein abundance was not impacted by HS in the presence of circulating 
gonadotrophins.   
The ovary from post-pubertal, estrous synchronized gilts had detectable levels of ABCC1 
mRNA.  HS for 5 d during follicular development did not alter (P = 0.09) the abundance 
of mRNA encoding ABCC1 (Figure 3.6).  ABCC1 protein abundance, in correspondence, 
was not impacted (P = 0.52) by HS in post-pubertal gilts exposed to HS during the follicular 
phase of the estrous cycle (Figure 3.7).   
 
HS impacts SULT1E1 protein abundance in post-pubertal gilts 
Similar to those effects of HS on SULT1E1 protein level observed in the pre-pubertal gilt 
ovary, there was an impact (P = 0.04) of HS on the abundance of SULT1E1 protein in the 
estrous synchronized post-pubertal gilt (Figure 3.8).        
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Discussion 
Productivity of commercial livestock agriculture is compromised by high environmental 
thermal temperatures [11].  HS causes economic losses in US livestock industries by 
reduction of dry matter intake (DMI) and body weight [11].  In terms of reproduction, HS 
affects female fertility and fecundity and is culpable for seasonal infertility, a period of 
reduced reproductive success characterized by an increased wean-to-estrus interval, 
reduced embryonic development and spontaneous abortion, altered follicular development.  
Seasonal infertility is estimated by our calculations to cost the US swine industry 
approximately $420 million annually (Pollman, Ross, Baumgard, Keating, unpublished 
data).  With climate models predicting hotter summer periods in areas with highest swine 
production, seasonal infertility as a consequence of HS in unlikely to abate in the future.   
 
Our previous findings demonstrated that HS altered ovarian proteins involved in 
folliculogenesis as well as steroidogenesis.  We discovered increased abundance of 
proteins involved in phosphatidylinositol-3 kinase (PI3K) signaling [24] which is critical 
for maintenance of follicle viability [35] as well as activation of primordial follicles into 
the growing follicular pool [5, 36, 37].  We also discovered increased insulin-mediated 
signaling [24], potentially as a response to hyperinsulinemia due to HS [11]. Ovarian 
mRNA abundance of genes involved in steroid hormone production were impacted by HS: 
increased LDLR, LHR, STAR and CYP19A1 were increased by HS – surprising 
considering that the animals were pre-pubertal.  Additionally, both StAR and CYP19A1 
protein abundance were increased in HS pre-pubertal gilt ovaries [24].  Considering that 
17β-estradiol is increased at the time of estrus in swine, any environmental perturbation 
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driving increased 17β-estradiol could alter estrus display as well as the LH surge inducing 
ovulation.  In this study, we evaluated whether there are HS-induced changes to the ovarian 
capacity to regulate 17β-estradiol ovarian concentrations.  If so, the increase in 
steroidogenic protein abundance previously observed could be attributable to increased 
degradation of 17β-estradiol and may represent a response to altered 17β-estradiol 
metabolism rather than a direct cause of perturbed ovarian function.    
 
SULT1E1, an enzyme that catalyzes the activity of estrogen sulfonation [26, 27], is present 
in porcine uterine endometrial tissue.  Maintaining an appropriate balance of estrogen 
within the ovary is regulated by SULT1E1 [38-40]. The role of SULT1E1 in porcine 
ovarian function has not been characterized, thus the data generated herein is novel and 
adds to our knowledge of ovarian basal functioning.  Appropriate estrogen levels are 
dependent on SULT1E1 [26].  In humans, SULT1E1 initiates the sulfoconjugation of 
estradiol and estrone at the 3-hydroxl terminal [26].  Studies have shown the action and 
abundance of SULT1E1 can impact fetal development [41], tumorigenesis of estrogen-
dependent cancers [42], and adipocyte differentiation [43].  A study using human umbilical 
vein endothelial cells (HUVECs) demonstrated high expression of SULT1E1 therein and 
that insulin-like growth factor (IGF-1), which is expressed in the ovary and functions as an 
endocrine/paracrine growth factor, upregulated SULT1E1 in vascular cells [26].  Furbass 
et al., also demonstrated that SULT1E1 was present in the bovine placentome of the 
binucleated trophoblast giant cells (TGCs) and uninucleated trophoplast cells (UTCs) [27].  
Higher levels of SULT1E1 mRNA was found in the TGCs compared to the UTCs, however 
UTCs protein expression was higher than TGCs [27]. This study suggested that UTCs are 
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the predominant cell type expressing SULT1E in the bovine due to its increased 
transcriptional levels in a location where free estrogens are sulfonated [27].  SULT1E1 
may play a major role in the protection of UTCs against estrogenic stimulation deriving 
from CYP19A1-expressing TGCs or by building a barrier for prevention of excessive free 
estrogen into the maternal compartment from the cotyledons in the bovine placentomes 
[27].  
 
In the Sult1e1-deficient mouse ovary, impaired ovulation and cumulus expansion response 
was observed [44]. This supports the notion that CYP19a and CYP11a1 enzymatic activity 
potentially induce expression of the SULT1E1 gene in response to the LH surge [45].  17β-
estradiol elevation in the Sult1e1-deficient mouse model disrupted the normal endocrine 
feedback mechanisms therefore potentially altering ovarian cellular functions [45].  Taken 
together, these studies provide validation of the importance of sulfonation of 17β-estradiol.  
Chronic HS increased ovarian SULT1E1 protein level in pre-pubertal gilts and also 
impacted 5d HS estrus synchronized post-pubertal gilts also by increasing SULT1E1 
protein levels.  These data indicate that ovarian SULT1E1 is involved in 17β-estradiol 
sulfonation and likely contributes to basal ovarian metabolism of 17β-estradiol.  These data 
also support that HS increased 17β-estradiol metabolism in ovaries of pre-pubertal gilts 
and post-pubertal gilts.  This could indicate that the previously observed increased StAR 
and CYP19A1 [24] represents a response to increased SULT1E1 during HS or vice versa.  
Future experiments that could address this would include evaluating the temporal patterns 
of both increased steroidogenesis and steroid degradation during HS in swine.    
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ABCC1, a drug transporter that is abundant in many tissues, transports endogenous and 
exogenous compounds throughout the body [25]. Its major function is to protect cells from 
damage [40].  ABCC1 is highly expressed in cancerous tissues and has been identified in 
human cell lung cancer lines that are resistant to anti-neoplastic agents [46].  Sulfonated 
17β-estradiol represents a substrate for ABCC1, thus ABCC1 is involved in 17β-estradiol 
metabolism [47] [26].  ABCC1 is also hypothesized to transport estrone 3-sulfate after 
catalysis by SULT1E1 because of its hydrophilic properties [48].  In contrast, Abcc1 
knockout-mice exhibited reduced concentrations of 17β-estradiol, androstenedione, and 
testosterone in the testicles [40].   This study presents the idea that steroid hormone levels 
in the gonad are involved in negative feedback loops of steroid regulation by possibly 
compensating the loss of Abcc1 with upregulating Cyp17 changing the proportion of 17β-
estradiol and estrone 3-sulfate [40]. However, information in regards to regulation of Abcc1 
in concert with Sult1e1 in the ovary is scant.   
 
We demonstrated that ABCC1 protein is detectable in the porcine ovary in pre-pubertal 
and post-pubertal gilts.  Following 7 d of HS treatment, there were no alterations at the 
transcriptional or translational levels of ABCC1 and no impact of reduced feed intake on 
ABCC1 was observed.  However, HS for 35 d increased ovarian ABCC1 protein 
expression, but did not impact ABCC1 at the mRNA level in pre-pubertal gilts.  ABCC1 
mRNA abundance nor ABCC1 protein abundance was impacted by HS in post-pubertal 
gilts.  Our data demonstrate for the first time that ABCC1 is regulated dynamically in the 
gilt ovary.  We also have discovered a response to HS in ABCC1 protein level, though 
76 
 
disparities in this response are dependent on ovarian status as well as on the duration of the 
HS event.    
 
Consideration of the ovarian status in the porcine models used is necessary to appreciate 
the biological meaning of our findings.  Chronic HS in the post-pubertal gilt increased both 
ABCC1 and SULT1E1 protein expression, possibly indicating that ABCC1 is transporting 
the SULT1E1-catalyzed sulfonated 17β-estradiol out of the cell.  HS increased SULT1E1 
could be indicative of an overproduction of 17β-estradiol or it could have resulted from 
increased excretion of 17β-estradiol due to the age of the gilts.  There were no alterations 
in ABCC1 mRNA or ABCC1 protein levels post HS treatment during the follicular phase 
in post-pubertal gilts, however, SULT1E1 protein levels were increased due to HS 
exposure. The fact that there were no changes observed in ABCC1 transcriptionally or 
translationally but an increase in SULT1E1 protein due to HS could be indication that there 
are high levels of 17β-estradiol present, therefore, sulfonation needed.  In addition, though 
there were no significant changes in ABCC1 mRNA or protein abundance due to HS, our 
data demonstrates that mRNA levels decreased while protein levels were increased. Longer 
treatment exposure to HS could have possibly shown a significant decrease in ABCC1 
mRNA and significant increase in ABCC1 protein which would be required for 17β-
estradiol extracellular transport for regulation.   
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Chapter 3 Figures 
 
Figure 3.1. Ovarian ABCC1 mRNA not impacted by acute HS in the pre-pubertal gilt.   
Quantification of ovarian ABCC1 mRNA was performed using RT-PCR from total RNA 
isolated from pre-pubertal gilt ovaries exposed to thermal neutral (TN; 20°C; 35-50% 
humidity; n = 5-6) or heat stress (HS; 35°C; 20-35% humidity; n = 5-6) conditions for 7 (n 
= 5 per treatment) days.  An additional group of gilts who were pair fed (PF) to those 
experiencing HS were included to account for dissimilar feed intake.  Data represents mean 
fold-change in mRNA abundance between treatments; P = 0.44. 
 
Treatment
R
e
la
ti
v
e
 A
B
C
C
1
 m
R
N
A
 L
e
v
e
l
TN PF HS
0.0
0.5
1.0
1.5
2.0
TN
PF
HS
79 
 
  
 
Figure 3.2. ABCC1 protein not impacted by HS in pre-pubertal gilt.  
Ovarian ABCC1 protein was quantified by western blotting from protein homogenates 
isolated from pre-pubertal gilt ovaries exposed to thermal neutral (TN; 20°C; 35-50% 
humidity; n = 5-6) or heat stress (HS; 35°C; 20-35% humidity; n = 5-6) conditions for 7 (n 
= 5 per treatment) days.  An additional group of gilts who were pair fed (PF) to those 
experiencing HS were included to account for dissimilar feed intake.  Data represents 
relative protein abundance between treatments.  The western blotting image as well as the 
ponceau S (PonS) total protein staining is provided.  Difference between treatments: P = 
0.49. 
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Figure 3.3.  Chronic HS does not impact ovarian ABCC1 mRNA in the pre-pubertal 
gilt.  
Quantification of ovarian ABCC1 mRNA was performed using RT-PCR from total RNA 
isolated from pre-pubertal gilt ovaries exposed to thermal neutral (TN; 20°C; 35-50% 
humidity; n = 5-6) or heat stress (HS; 35°C; 20-35% humidity; n = 5-6) conditions for 35 
(n = 3 per treatment) days.  Data represents mean fold-change in mRNA abundance 
between treatments; P = 0.38. 
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Figure 3.4.  Chronic HS increased ovarian ABCC1 protein abundance in pre-
pubertal gilts.  
Ovarian ABCC1 protein was quantified by western blotting from protein homogenates 
isolated from pre-pubertal gilt ovaries exposed to thermal neutral (TN; 20°C; 35-50% 
humidity; n = 5-6) or heat stress (HS; 35°C; 20-35% humidity; n = 5-6) conditions for 35 
(n = 3 per treatment) days.  Data represents relative protein abundance between treatments.  
The western blotting image as well as the ponceau S (PonS) total protein staining is 
provided.  * indicates different ABCC1 protein abundance between treatments; P = 0.01.     
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Figure 3.5.  Porcine ovarian SULT1E1 induced by HS in pre-pubertal gilts.    
Ovarian SULT1E1 protein was quantified by western blotting from protein homogenates 
isolated from pre-pubertal gilt ovaries exposed to thermal neutral (TN; 20°C; 35-50% 
humidity; n = 5-6) or heat stress (HS; 35°C; 20-35% humidity; n = 5-6) conditions for 35 
(n = 3 per treatment) days.  Data represents relative protein abundance between treatments.  
The western blotting image as well as the ponceau S (PonS) total protein staining is 
provided.  * indicates different SULT1E1 protein abundance between treatments;  P = 
0.003.    
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Figure 3.6.  ABCC1 mRNA level not altered in the post-pubertal gilt due to HS. 
Post-pubertal gilts were synchronized in estrous by Matrix® feeding for 14 days.  On the 
day after Matrix® withdrawal, gilts were exposed to TN (n = 6, 20.3°C ± 0.1°C) or HS (n 
= 6, 26-32°C) conditions for 5 d during the follicular phase.  ABCC1 mRNA was quantified 
from total ovarian RNA by RT-PCR and data is expressed as mean fold change between 
treatments; P = 0.09.     
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Figure 3.7.   HS does not impact ABCC1 protein abundance in the post-pubertal 
gilt.   
Post-pubertal gilts were synchronized in estrous by Matrix® feeding for 14 days.  On the 
day after Matrix® withdrawal, gilts were exposed to TN (n = 6, 20.3°C ± 0.1°C) or HS (n 
= 6, 26-32°C) conditions for 5 d during the follicular phase.  ABCC1 protein was quantified 
from total ovarian protein homogenates by western blotting and data is expressed as 
relative protein abundance between treatments; P = 0.51.    
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Figure 3.8.  HS increased SULT1E1 protein abundance in post-pubertal gilts.   
Post-pubertal gilts were synchronized in estrous by Matrix® feeding for 14 days.  On the 
day after Matrix® withdrawal, gilts were exposed to TN (n = 6, 20.3°C ± 0.1°C) or HS (n 
= 6, 26-32°C) conditions for 5 d during the follicular phase.  SULT1E1 protein was 
quantified from total ovarian protein homogenates by western blotting and data is 
expressed as relative protein abundance between treatments.  * indicates different 
SULT1E1 protein abundance between treatments; P = 0.04.    
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CHAPTER 4 
 
GENERAL DISCUSSION AND CONCLUSIONS 
 
The reviewed literature and data offered in this thesis highlight the importance of intact 
metabolic processes for conservation of life.  As the mammalian ovary is comprised with 
a finite primordial follicular pool that could result in sterility if depleted, it is imperative 
that appropriate defense mechanisms are opposed to the effects of ovotoxicants.  
Investigations of potential detoxification regulatory pathways and biotransformation 
enzymes were conducted in this study as well as regulation of homeostatic physiological 
processes that can be negatively influenced by toxicants or natural environmental 
occurrences. Chapter 4 will contain the author’s inclusive interpretation of the literature 
reviewed, experimental studies, and future research considerations. 
 
Impact of PM on ABC drug transporters 
Phosphoramide Mustard (PM) is the ovotoxic metabolite of the chemotherapeutic reagent 
cyclophosphamide (CPA) [1].  CPA-induced ovotoxicity resulted in depletion of follicles 
by targeting granulosa cells in a mouse model [2].  We previously demonstrated that PM 
(60 µM) exposure in a postnatal day 4 (PND4) cultured rat ovarian model reduced all 
follicle types by day 4 of treatment [3]. The ovotoxicant also has the capability to disrupt 
DNA integrity to alter the follicular reserve by depleting primordial and primary follicles 
[4].  Loss of the ovarian follicular reserve leads to premature ovarian failure (POF) in 
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females [5], being that this destruction is irreversible.  In this thesis, ovarian detoxification 
and defense mechanism for cellular protection were examined.  We investigated the effect 
of PM exposure on adenosine triphosphate (ATP) binding cassette drug transporters, 
ABCB1 and ABCC1.  As previously discussed, these phase III biotransformation enzymes 
were discovered on the basis of their conferring multidrug resistance to cancer cells 
reducing the efficacy of chemotherapy treatment [6, 7].  ABCB1 transports uncharged or 
positively charged hydrophobic substrates converting them to hydrophilic forms by 
glutathione (GSH) conjugation, oxidative process with cytochrome P450 (CYP450) 
enzymes, or initial blockage from entering into cytoplasm of cell [6].  In contrast of 
substrate specificity, ABCC1 transports anionic compounds, conjugated GSH substrates, 
sulfates, and hydrophobic constituents [8-14].  In this study, two different models were 
used that included a cultured rat spontaneously immortalized granulosa cell (SIGC) line 
and postnatal day 4 whole ovarian culture.  SIGCs were used because somatic cell signaling 
is vital for follicle development as they contain follicle stimulating hormone (FSH) 
receptors [15].  The in vitro whole ovarian model allowed greater insight of intracellular 
interaction with the oocyte and granulosa cell in response to toxicants and the chemical 
response within different follicular stages.    
 
PM exposure to SIGCs or PND4 rat ovaries did not affect ABCC1 protein abundance 
compared to the control.  However, a biological reduction in ABCB1 protein expression 
was observed in PND4 ovaries after PM exposure.  Though both drug transporters have 
GSH substrate specificity, ABCB1 undergoes an oxidative process via CYP450 activity 
and studies have indicated that overexpression of CYP450 enzymatic activity potentially 
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inactivates anticancer drugs, as the presence of these enzymes are seen in tumors [16-19]. 
CPA undergoes hepatic biotransformation via CYP450 enzymes suggesting that ABCB1 
could potentially bind to PM and export it out the cell decreasing its expression or that the 
drug transporter viability is susceptible to PM-induced reduction in non-cancerous cells.  
Danker et al. (2013) demonstrated decreased ABCB1 and ABCC1 transport activity with 
the endocrine disruptors’ tetrabromobisphenol A (TBBPA) and perfluorooctanoic acid 
[20].  Protein abundance of ABCC1 may not have been relevant to PM exposure as it 
belongs to a separate subfamily of ABC superfamily demonstrating that ABCB1 may have 
a higher binding affinity for PM [21].   
 
Localization of ovarian ABCB1 and ABCC1 in PND4 ovaries was also investigated to 
understand regional expression in various follicular stages.  ABCC1 was localized in the 
oocyte nucleus of small follicles in PND4 ovaries, while increased expression was 
observed in maturing follicles. ABCB1 expression was confined to the oocyte cytoplasmic 
region and increased abundance was observed in growing pre-antral follicles. Similarly, 
starfish and porcine somatic cells and oocyte demonstrated increased expression of ABCB1 
in developing follicles [22-25].  ABC proteins transport function relies on hydrolysis of 
ATP with cytoplasmic domains [6].   In vivo PM exposed adult mice expressed ABCC1 
protein in interstitial tissue, oocyte cytoplasm, nucleus of oocyte and oocyte peri-
cytoplasmic and peri-nuclear membrane of control treated mice in pre-ovulatory follicles.  
However, peri-cytoplasmic and peri-nuclear ABCC1 fluorescence was not observed in 
PM-exposed ovaries, likely due to the severity of PM-induced follicle damage that was 
evident. ABCB1 expression in this model was confined to granulosa cells, interstitial 
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tissue, oocyte, peri-nuclear and peri-cytoplasmic region of pre-ovulatory follicles post-PM 
exposure.  Localization of ABCB1 was found in the peri-nuclear area of the cytoplasm in 
non-metaplastic chronic gastric human fetuses [26].   
 
It was quite interesting that ABCB1 protein abundance of PND4 was altered by PM 
exposure as it was also restrained to the oocyte’s cytoplasmic region, while, ABCC1 
protein levels were unaltered and localized to the nucleus of the oocyte. This information 
may suggest that ABCB1 plays a role in regulation of PM transport from the cytoplasm as 
a defensive mechanism.   
 
Regulation of phase III biotransformation enzymes via PI3K signaling 
Phosphatidylinositol-3 kinase signaling (PI3K) is an intracellular pathway that promotes 
cell proliferation. Primordial viability and follicular recruitment depend on this pathway 
[27-30].    PI3K activation is by binding the oocyte c-kit receptor by kit ligand (KL), that 
is formed in the granulosa cells.   KL plays a vital role in oogenesis and folliculogenesis in 
the preantral stage [31].  It is expressed in granulosa cells of several species, including the 
rat, ovine, and human [31-33].  KL can be expressed as a membrane-associated protein 
(KL-2) or soluble protein (KL-1) [31, 34] but translation results in membrane-associated 
products [31].  KL-2 is the main isoform for growth and oocyte survival [31] and both 
forms are present in the rodent model [31, 32].  The oocyte receptor, c-Kit, is present during 
postnatal ovarian development of all follicle stages [31].   PI3K is involved in regulation 
of ovarian chemical biotransformation enzymes. Our previous studies displayed that PI3K 
inhibition altered the mRNA and protein abundance of Nrf2, Gstp, AhR, and Gstm, 
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implying that PI3K has a regulatory role in phase I and phase II chemical biotransformation 
[35, 36].   
 
We investigated regulation of ABCC1 and ABCB1 via the PI3K signaling pathway.  PND4 
rat ovarian culture model was used, so ovaries were comprised of primordial and small 
primary follicles.  Ovaries were treated with the PI3K inhibitor, LY294002, and the PI3K 
activator, KL.  PI3K signaling was observed to regulate ABCC1 and ABCB1 protein in 
PND4 rat ovaries.  Inhibition of PI3K nearly depleted the total abundance of ABCC1 while 
PI3K activation did not alter the drug transporter when compared to the control.  Deficiency 
of PI3K also reduced ABCB1 protein level, though not to the extent of ABCC1, and again 
KL treatment did not impact ABCB1.   Imai et al., demonstrated inhibition of ABCB1 and 
ABCC1 in prostate cancer cells following LY294002 treatment [37, 38].  Surprisingly, no 
impact on ABCC1 or ABCB1 protein was noted due to overactivation of PI3K with KL.  
An in vitro study showed that KL (100 ng/ml) increased follicular growth of rat primordial 
to primary follicles after 5-14 d of culture [31, 39]. They suggested that low levels of KL 
may not be sufficient to promote follicular development.  In this particular study 400ng/ml 
of KL was used in the cultured system ensuing PI3K activation and follicular growth as 
this had previously been demonstrated to prevent VCD-induced follicle depletion in the 
cultured rat ovary system [40].   
 
Though KL treatment had no impact on phase III biotransformation enzymes, inhibition of 
PI3K signaling demonstrated that ABCB1 and ABCC1 are downstream of the pathway. 
Additional information on phase III biotransformation enzymes will aid in gaining more 
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insight about detoxification and defensive mechanisms of the ovary that would further our 
understanding of reproductive science.   
 
Impact of HS on ovarian ABCC1 and SULT1E1 in the pig  
The porcine reproductive cycle, which is very similar to the human, can be negatively 
affected disrupted by heat stress (HS).  HS is a biological response to increased body 
temperature [41-43] which impacts agriculture livestock production [44].  HS disrupts the 
development and function of mammalian reproduction by impairing hormone production 
secretions, embryo development [15, 16], ovarian folliculogenesis [16, 17], and uterine 
environment [18, 19].  Studies have reported seasonal infertility, reduced implantation 
rates, impairment of embryo development, and prolonged weaning related to HS in gilts 
and sows [14, 20-22].  Our research group has previously demonstrated that HS altered 
PI3K signaling, which is involved in primordial follicle activation, maturation, and ovarian 
steroidogenesis [45]. Also, 7 or 35 d of HS in pre-pubertal gilts increased aromatase 
(CYP19a1) and steroidogenic acute regulatory protein (STAR) both transcriptionally and 
at the protein level [45].    
 
We hypothesized that HS alters balance of the steroidogenic process and the hypothalamic 
pituitary gonadal axis (HPG) potentially disrupting 17β-estradiol.  SULT1E1 is an enzyme 
that catalyzes sulfonation of estrogens, converting them into an inactive form which is 
transported extracellularly by ABCC1.  Although, SULT1E1 had not previously been 
described in the ovary of swine, it had been characterized in the porcine uterine 
endometrium [46].  We made the novel finding that SULT1E1 is also expressed in the 
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ovary.   The two pig models that were included in this investigation were pre-pubertal gilts 
and post-pubertal gilts that were estrus synchronized.  Post-pubertal gilts were 
synchronized to ensure they were at the same follicular stage of development, thereby 
eliminating variables that could alter observed data.   To ensure elimination of bias of 
dissimilar feed intake, in the pre-pubertal 7 d gilts, an additional group of thermoneutral 
gilts were pair-fed to their HS cohorts.  Additionally, in the post-pubertal gilts, all received 
the same feed amount, regardless of treatment.  We demonstrated no changes in ovarian 
ABCC1 protein or mRNA level due to 7 d of HS.  Chronic HS for 35 d increased ABCC1 
and SULT1E1 in pre-pubertal gilts compared to relative controls.  Up-regulation of both 
SULT1E1 and ABCC1 could be indicative of increased 17β-estradiol potentially impairing 
the steroidogenic response leading to poor reproductive function by decreasing 
fertilization, oocyte viability, impairment of fetal growth, and spontaneous abortions that 
are indeed phenotypes observed in HS animals.  It could also be proposed that ABCC1 
detoxifies the sulfate conjugated 17β-estradiol out of the ovary thereby sending a feedback 
signal to the HPG axis.  Post-pubertal gilts ABCC1 mRNA levels or protein levels were 
not altered following 5 d of HS exposure, however SULT1E1 protein expression was 
increased.  The data generated from 5 d HS post-pubertal gilts were variable which is 
surprising considering that ovaries were collected at the same stage of the estrous cycle.  
The changes could be from different follicle stages therefore immunostaining to localize 
SULT1E1 and ABCC1 is a future experiment that is warranted.  
 
As previously discovered by our research group [45], increased levels of CYP19A1 and 
STAR in pre-pubertal gilts following 7 and 35 d of HS and the findings in this thesis of 
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significant increases in SULT1E1, the sulfonation catalytic enzyme, and up-regulation of 
ABCC1, transporter of sulfonated substrates, provide additional evidence that HS has the 
potential to be an endocrine disruptor.   Though little information is known about the 
regulation and elimination of ABCC1 and its substrates, further investigations are required. 
 
Future Research 
The course of this experimental data expressed novel findings, however there are unknown 
variables that need to be addressed.  We demonstrated no impact of PM on ABCC1 protein 
abundance in PND4 rat ovaries, however there was a slight reduction in ABCB1 
abundance. An impact could have been observed in ABCC1 protein abundance with 
extended PM exposure to PND6 and possibly a more significant alteration in ABCB1 trend.  
Being that both drug transporters are GSH substrates it would have been interesting to 
follow up the previous study from our group [47] that demonstrated GSH supplementation 
during PM exposure reduced PM-induced follicle loss in all follicle types and GSH 
depletion during PM exposure resulted in depletion of all follicle stages.  Investigation of 
ABCC1 and ABCB1 metabolic roles with GSH supplementation or depletion during PM 
exposure on follicle loss and protein abundance could instigate better detoxification 
techniques for preservation of the ovarian follicular reserve and improve understanding of 
biotransformation enzymatic activity. A transport interaction assay of ABCC1 and ABCB1 
could also expand knowledge regarding interaction with PM and functional susceptibilities 
to the compound, as demonstrated by [20]. 
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Phase III biotransformation enzymes are regulated via the PI3K signaling pathway.  
Inhibition of PI3K resulted in reduced protein abundance of ABCC1 and ABCB1, 
however, PI3K activation via KL had no impact. There are two isoforms of KL, KL-1 being 
soluble and KL-2 that remains membrane bound.  KL-2 is the main isoform that is for 
growth and survival of the oocyte [31, 48].  Alteration to the KL-2 isoform used as the 
activator of PI3K could help resolve this confounding discovery.  Studies have shown that 
even though Kl expression is high in at the transcriptional level in primordial follicles 
obtained at birth, it is not present at the translational level suggesting that KL-treated PND4 
rat ovaries did not have the capability of proper activation resulting in unaltered levels of 
ABCB1 and ABCC1.  We could also examine c-Kit expression in the KL-treated ovarian 
culture to ensure that system did not defect the functionality of the oocyte receptor.  A more 
economical approach to determining PI3K activation in the PND4 ovarian culture is also 
to count the number of developing follicles compared to the control as the KL treatment 
should have initiated such process. 
 
The investigation of HS in porcine ovarian steroidogenic response revealed no changes in 
SULT1E1 or ABCC1 protein or in their mRNA levels post 7 d of HS in pre-pubertal gilts.  
Chronic HS (35 d) did increase both substrates potentially indicating that HS could lead to 
impairment of steroidogenic production by altering 17β-estradiol or it could demonstrate 
that sulfonation and transportation via ABCC1 is a regulatory process for excessive active 
estrogens that could inflict poor reproduction in pre-pubertal gilts. Cyclic gilts resulted in 
variable data: increased SULT1E1 protein abundance post 5 d HS exposure, but no impact 
on ABCC1 mRNA expression. For further investigation of this study, luteinizing hormone 
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(LH) levels should be determined as it increases 17β-estradiol leading to problematic 
reproductive consequences.  Immunohistochemistry (IHC) of ABCC1 and SULT1E1 of 
porcine ovarian tissue slices would have provided visual evidence of localization and 
abundance of these proteins.   
 
Information regarding phase III ovarian biotransformation enzymes is scant and expanded 
knowledge on this topic could shed light on possible mechanisms and techniques that can 
preserve the quality of the ovary and life of women who are exposed to detrimental 
senescence-induced ovotoxicants.  Further characterization and investigation of SULT1E1 
and ABCC1 function and substrate transportation could relieve HS abnormalities that are 
seen in livestock production that leads to huge economic losses.  In conclusion, the 
collective purpose of the research described in this thesis was to increase our understanding 
regarding harmful toxicants and unbalanced environmental conditions to enhance 
reproductive health in humans and animals.   
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APPENDIX: SUPPLEMENTAL DATA  
 
 
 
 
 
(A) (B) 
Figure 1.1.  Antibody negative controls for western 
blots. 
PND4 rat ovaries were cultured for 4 d in media 
containing vehicle control (CT; DMSO) or gilts exposed 
to control conditions (TN; 20.3°C) followed by total 
protein isolation and western blotting.  Letters indicate 
specific antibody tested: (A): ABCC1, 1° only; (B): 
ABCB1, 1° only; (C): Goat Anti-Rabbit HRP, 2° only; 
(D): Normal Goat IgG/Goat Anti-Rabbit HRP, 1° and 2°; 
(E): SULT1E1, 1° only.  Antibodies in lanes A-D were 
tested against rat ovarian tissue and lane E utilized 
porcine ovarian tissue.  Black block arrow indicates the 
protein ladder residue present on blot. 
(C) (D) (E) 
